10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: June 30, 2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-31990

TEL-INSTRUMENT ELECTRONICS CORP.

(Exact name of registrant as specified in its charter)

New Jersey	22-1441806
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

One Branca Road

East Rutherford, NJ 07073

(Address of principal executive offices)

(201) 933-1600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
N/A	N/A	N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months, and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large, accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large, accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of August 11, 2022, there were 3,255,887 shares outstanding of the registrant’s common stock.

TEL-INSTRUMENT ELECTRONICS CORP.

TABLE OF CONTENTS

PART I – FINANCIAL INFORMATION
		Page
Item 1.	Unaudited Condensed Consolidated Financial Statements.	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	18
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	22
Item 4.	Controls and Procedures.	22
PART II – OTHER INFORMATION
Item 1.	Legal Proceedings.	23
Item 1A.	Risk Factors.	23
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	23
Item 3.	Defaults Upon Senior Securities.	23
Item 4.	Mine Safety Disclosures.	23
Item 5.	Other Information.	23
Item 6.	Exhibits.	24
Signatures		25

PART I – FINANCIAL INFORMATION

Item 1. Unaudited Condensed Consolidated Financial Statements.

TEL-INSTRUMENT ELECTRONICS CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

	June 30, 2022			March 31, 2022
	(unaudited)
ASSETS
Current assets:
Cash	$	4,249,794		$	4,949,690
Accounts receivable, net of allowance for doubtful accounts of $7,425, respectively		1,372,327			1,049,040
Inventories, net		2,695,928			2,820,497
Restricted cash to support appeal bond		2,011,050			2,011,050
Prepaid expenses and other current assets		399,118			244,040
Total current assets		10,728,217			11,074,317
Equipment and leasehold improvements, net		111,127			115,338
Operating lease right-of-use assets		1,673,036			1,720,921
Deferred tax asset, net		2,561,504			2,499,587
Other long-term assets		35,109			35,109
Total assets	$	15,108,993		$	15,445,272
LIABILITIES & STOCKHOLDERS’ EQUITY
Current liabilities:
Operating lease liabilities – current portion	$	196,271		$	194,370
Accounts payable		167,426			406,489
Deferred revenues - current portion		170,575			119,835
Accrued expenses ‐vacation pay, payroll and payroll withholdings		424,781			410,538
Accrued legal damages		6,149,193			6,097,273
Accrued expenses - other		345,857			174,145
Total current liabilities		7,454,103			7,402,650
Operating lease liabilities – long-term		1,476,765			1,526,551
Deferred revenues – long-term		257,759			289,071
Total liabilities		9,188,627			9,218,272
Commitments and contingencies
Stockholders’ equity:
Preferred stock, 1,000,000 shares authorized, par value $0.10 per share
Preferred stock, 500,000 shares 8% Cumulative Series A Convertible Preferred issued and outstanding, par value $0.10 per share		3,695,998			3,695,998
Preferred stock, 166,667 shares 8% Cumulative Series B Convertible Preferred issued and outstanding, par value $0.10 per share		1,147,367			1,147,367
Common stock, 7,000,000 shares authorized, par value $0.10 per share, 3,255,887 and 3,255,887 shares issued and outstanding, respectively		325,586			325,586
Additional paid-in capital		6,944,588			7,018,353
Accumulated deficit		(6,193,173	)		(5,960,304	)
Total stockholders’ equity		5,920,366			6,227,000
Total liabilities and stockholders’ equity	$	15,108,993		$	15,445,272

See accompanying notes to unaudited condensed consolidated financial statements.

3

TEL-INSTRUMENT ELECTRONICS CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended
	June 30, 2022			June 30, 2021
Net sales	$	2,253,757		$	4,132,393
Cost of sales		1,418,572			2,117,646
Gross margin		835,185			2,014,747
Operating expenses:
Selling, general and administrative		556,209			554,031
Litigation expenses		724			1,181
Engineering, research, and development		522,103			693,575
Total operating expenses		1,079,036			1,248,787
(Loss) income from operations		(243,851	)		765,960
Other (expense) income:
Interest income		986			984
Other income		-			13,593
Interest expense – judgement		(51,920	)		(51,920	)
Total other expense, net		(50,934	)		(37,343	)
(Loss) income before income taxes		(294,785	)		728,617
Income tax (benefit) expense		(61,916	)		153,116
Net (loss) income		(232,869	)		575,501
Preferred dividends		(80,000	)		(80,000	)
Net (loss) income attributable to common shareholders	$	(312,869	)	$	495,501
Basic net (loss) income per common share	$	(0.10	)	$	0.15
Diluted net (loss) income per common share	$	(0.10	)	$	0.11
Weighted average shares outstanding:
Basic		3,255,887			3,255,887
Diluted		3,255,887			5,095,665

See accompanying notes to unaudited condensed consolidated financial statements.

4

TEL-INSTRUMENT ELECTRONICS CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

For the Three Months Ended June 30, 2022 and 2021

(Unaudited)

	Series A Convertible Preferred Stock					Series B Convertible Preferred Stock					Common Stock
	# of Shares Issued		Amount			# of Shares Issued		Amount			# of Shares Issued		Amount		Additional Paid-In Capital			Accumulated Deficit			Total
Balances at April 1, 2022		500,000	$	3,695,998			166,667	$	1,147,367			3,255,887	$	325,586	$	7,018,353		$	(5,960,304	)	$	6,227,000
8% Dividends on Preferred Stock		-		60,000			-		20,000			-		-		(80,000	)		-			-
Dividend Payments		-		(60,000	)		-		(20,000	)		-		-		-			-			(80,000	)
Stock-based compensation		-		-			-		-			-		-		6,235			-			6,235
Net loss		-		-			-		-			-		-		-			(232,869	)		(232,869	)
Balances at June 30, 2022		500,000	$	3,695,998			166,667	$	1,147,367			3,255,887	$	325,586	$	6,944,588		$	(6,193,173	)	$	5,920,366

	Series A Convertible Preferred Stock					Series B Convertible Preferred Stock					Common Stock
	# of Shares Issued		Amount			# of Shares Issued		Amount			# of Shares Issued		Amount		Additional Paid-In Capital			Accumulated Deficit			Total
Balances at April 1, 2021		500,000	$	3,695,998			166,667	$	1,147,367			3,255,887	$	325,586	$	7,318,620		$	(7,270,042	)	$	5,217,529
8% Dividends on Preferred Stock		-		60,000			-		20,000			-		-		(80,000	)		-			-
Dividend Payments		-		(60,000	)		-		(20,000	)		-		-		-			-			(80,000	)
Stock-based compensation		-		-			-		-			-		-		6,168			-			6,168
Net income		-		-			-		-			-		-		-			575,501			575,501
Balances at June 30, 2021		500,000	$	3,695,998			166,667	$	1,147,367			3,255,887	$	325,586	$	7,244,788		$	(6,694,541	)	$	5,719,198

See accompanying notes to unaudited condensed consolidated financial statements.

5

TEL-INSTRUMENT ELECTRONICS CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Three Months Ended
	June 30, 2022			June 30, 2021
Cash flows from operating activities:
Net (loss) income	$	(232,869	)	$	575,501
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities
Deferred income taxes		(61,917	)		153,114
Depreciation and amortization		15,944			31,381
Non-cash lease expense		47,885			55,300
(Recovery of) provision for inventory obsolescence		(25,048	)		-
Non-cash stock-based compensation		6,235			6,168
Changes in assets and liabilities:
(Increase) decrease in accounts receivable		(323,287	)		615,045
Decrease in inventories		149,617			386,646
(Increase) decrease in prepaid expenses & other assets		(155,078	)		3,514
(Decrease) in accounts payable and other accrued liabilities		(67,351	)		(555,716	)
Increase in accrued payroll, vacation pay and payroll taxes		14,243			84,842
Increase in deferred revenues		19,428			1,129
(Decrease) in operating lease liabilities		(47,885	)		(55,300	)
Increase in accrued legal damages		51,920			51,920
Net cash (used in) provided by operating activities		(608,163	)		1,353,544
Cash flows from investing activities:
Purchases of equipment		(11,733	)		-
Net cash used in investing activities		(11,733	)		-
Cash flows from financing activities:
Payment of dividends		(80,000	)		(80,000	)
Net cash used in financing activities		(80,000	)		(80,000	)
Net (decrease) increase in cash and restricted cash		(699,896	)		1,273,544
Cash and restricted cash at beginning of period		6,960,740			5,496,325
Cash and restricted cash at end of period	$	6,260,844		$	6,769,869
End of period
Cash	$	4,249,794		$	4,758,819
Restricted cash		2,011,050			2,011,050
	$	6,260,844		$	6,769,869
Beginning of period
Cash	$	4,949,690		$	3,485,275
Restricted cash		2,011,050			2,011,050
	$	6,960,740		$	5,496,325
Supplemental cash flow information:
Taxes paid	$	-			-
Interest paid	$	-		$	-

Supplemental disclosure of non-cash financing activities:

See accompanying notes to unaudited condensed consolidated financial statements.

6

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 – Business, Organization and Liquidity

Business and Organization

Tel-Instrument Electronics Corp. (“Tel,” “TIC” or the “Company”) has been in business since 1947. The Company is a leading designer and manufacturer of avionics test and measurement instruments for the global, commercial air transport, general aviation, and government/military defense markets. Tel provides instruments to test, measure, calibrate, and repair a wide range of airborne navigation and communication equipment. The Company sells its equipment in both domestic and international markets. Tel continues to develop new products in anticipation of customers’ needs and to maintain its strong market position. Its development of multi-function testers has made it easier for customers to perform ramp tests with less operator training, fewer test sets, and lower product support costs. The Company has become a major manufacturer and supplier of Identification Friend or Foe (“IFF”) flight line test equipment over the last two decades.

The Company is publicly traded and was quoted on the Over-the-Counter Market Place (“OTCQB”) under the symbol “TIKK.”

Liquidity

On June 30, 2022, the Company had positive working capital of $3,274,114, as compared to working capital of $3,671,667 on March 31, 2022. This included $6.3 million of cash including the $2 million supersedes appeal bond. The Company also has current borrowing capacity of $690,000 under the Company’s line of credit agreement. The Company has recorded total damages of $6,149,193, including accrued interest, as a result of the jury verdict associated with the Aeroflex litigation as well as the Court’s decision on punitive damages.

There was a $2.7 million sales order backlog on June 30, 2022.

Bank of America has renewed our line of credit with a maturity date of July 30, 2023. As of June 30, 2022, the line of credit draw remains at zero, with $690,000 available.

Moving forward, we believe that our expected cash flows from operations and current cash balances, which amounted to approximately $6.3 million, including the approximately $2 million in restricted cash will be sufficient to operate in the normal course of business for next 12 months from the issuance date of these unaudited condensed consolidated financial statements, including any payments for settlement of the litigation. We are currently seeing supply chain lead times improving enough to allow fulfillment of our back log orders for the balance of the fiscal year.

Currently, the Company has no material future capital expenditure requirements.

In December 2019, a novel strain of coronavirus, which causes the disease known as COVID-19, was reported to have surfaced in Wuhan, China. Since then, COVID-19 coronavirus has spread globally. In March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic and the U.S. government imposed travel restrictions on travel between the United States, Europe, and certain other countries. The impact of this pandemic has been, and will likely continue to be, extensive in many aspects of society, which has resulted, and will likely continue to result, in significant disruptions to the global economy as well as businesses and capital markets around the world.

Impact of the COVID-19 Coronavirus

On September 9, 2021, President Biden announced Executive Order 14042 (“Executive Order”) and related initiatives designed to lead the country out of the COVID-19 pandemic. The Executive Order includes policies that will require employees of contractors that do business with the federal government to be vaccinated. On September 24, 2021, The Safer Federal Workforce Task Force released COVID-19 vaccine guidance for Federal contractors and subcontractors. According to this guidance, covered employees must be fully vaccinated by December 8, 2021, or at the latest, by the first day of performance on a covered contract, absent the need for a disability or religious accommodation. In addition, covered contractors must follow the CDC’s mask and physical distance requirements for covered contractor employees and visitors. The Executive Order and the guidance apply to any prime contractor or subcontractor that is a party to a “contract or contract-like instrument” that includes a clause incorporating the requirements of the Executive Order. The new clause was applied on October 15, 2021, to only new federal contracts, solicitations, contract extensions and renewals.

7

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 – Business, Organization and Liquidity (continued)

On December 7, 2021, the federal court in Georgia issued a preliminary injunction temporarily halting the enforcement of EO 14042 (Ensuring Adequate COVID Safety Protocols for Federal Contractors) for all covered contracts nation-wide. New guidance from OMB also followed suit giving federal agencies input on how to go about non-enforcement provisions until legal challenges have been resolved. The updated guidance will remain applicable despite any change to new or existing court decisions. The new guidance does not impact the Safer Federal Workforce Taskforce Guidance. The Government will take no action to enforce the clause implementing requirements of Executive Order 14042, absent further written notice from the agency, where the place of performance identified in the contract is in a U.S. state or outlying area subject to a court order prohibiting the application of requirements pursuant to the Executive Order (hereinafter, “Excluded State or Outlying Area”). In all other circumstances, the Government will enforce the clause, except for contractor employees who perform substantial work on or in connection with a covered contract in an Excluded State or Outlying Area, or in a covered contractor workplace located in an Excluded State or Outlying Area.

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Tel-Instrument Electronics Corp. as of June 30, 2022, the results of operations, change in stockholders’ equity for the three months ended June 30, 2022 and June 30, 2021, and statements of cash flow for the three months ended June 30, 2022 and June 30, 2021. These results are not necessarily indicative of the results to be expected for the full year. The unaudited condensed consolidated financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include disclosures normally made in an Annual Report on Form 10-K. The March 31, 2022, balance sheet included herein was derived from the audited financial statements included in the Company’s Annual Report on Form 10-K as of that date. Accordingly, the unaudited condensed consolidated financial statements included herein should be reviewed in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, as filed with the United States Securities and Exchange Commission (the “SEC”) on June 17, 2022 (the “Annual Report”).

Revenue Recognition

Under Financial Accounting Standards Board (“FASB”) Topic 606, Revenue from Contacts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods or services, in an amount that reflects the consideration which is expected to be received in exchange for those goods or services. The Company recognizes revenue following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods and services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.

The Company accounts for revenue recognition in accordance with ASC 606.The core principle of Topic 606 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The ASC 606 defines a five-step process to achieve the core principle and, in doing so, it is possible more judgement and estimates may be required within the revenue recognition process than are currently in use.

The Company generates revenue from designing, manufacturing, and selling avionic tests and measurement solutions for the global commercial air transport, general aviation, and government/military aerospace and defense markets. The Company also offers calibration and repair services for a wide range of airborne navigation and communication equipment.

8

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 2 – Summary of Significant Accounting Policies (continued)

Nature of goods and services

The following is a description of the products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each.

Test Units/Sets

The Company develops and manufactures unit sets to test navigation and communication equipment, such as ramp testers and bench testers for equipment installed in aircraft and ground radios. The Company recognizes revenue when the customer obtains control of the Company’s product based on the contractual shipping terms of the contract, which is usually at the time of shipment. Revenue on products is presented gross because the Company is primarily responsible for fulfilling the promise to provide the product, is responsible to ensure that the product is produced in accordance with the related supply agreement and bears the risk of loss while the inventory is in-transit. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products to the customer.

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines stand-alone selling prices based on the price at which the performance obligation is sold separately. If the stand-alone selling price is not observable through past transactions, the Company estimates the standalone selling price considering available information such as market conditions and internally approved pricing guidelines related to the performance obligations.

When determining the transaction price of a contract, an adjustment is made if payment from the customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying the practical expedient in paragraph 606-10-32-18, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less. None of the Company’s contracts contained a significant financing component as of June 30, 2022.

Replacement Parts

The Company offers replacement parts for test equipment, ramp testers, and bench testers. Similar to the sale of test sets, the control of the product transfers at a point of time and therefore, revenue is recognized at the point in time when the obligation to the customer has been fulfilled.

Extended Warranties

The extended warranties sold by the Company provide a level of assurance beyond the coverage for defects that existed at the time of a sale or against certain types of covered damage with coverage terms ranging from 3 to 7 years. Amounts received for warranties are recorded as deferred revenue and recognized as revenue ratably over the respective term of the agreements. As of June 30, 2022, $366,966 is expected to be recognized from remaining obligations for extended warranties as compared to $386,907 at March 31, 2022. For the three months ended June 30, 2022, the Company recognized revenue of $23,541 from amounts that were included in Deferred Revenue as compared to $15,915 from amounts that were included in Deferred Revenue for the three months ended June 30, 2021.

The following table provides a summary of the changes in deferred revenues for the three months ended June 30, 2022:

Deferred revenues at April 1, 2022	$	386,907
Additional extended warranties		3,600
Revenue recognized for the three months ended June 30, 2022		(23,541	)
Deferred revenues at June 30, 2022	$	366,966

9

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 2 – Summary of Significant Accounting Policies (continued)

Other Deferred Revenues

The Company sometimes receives payments in advance of shipment. These amounts are classified as other deferred revenues. For the periods ended June 30, 2022, and March 31, 2022, the Company had other deferred revenues of $61,368 and $21,999, respectively.

Repair and Calibration Services

The Company offers repair and calibration services for units that are returned for annual calibrations and/or for repairs after the warranty period has expired. The Company repairs and calibrates a wide range of airborne navigation and communication equipment. Revenue is recognized at the time the repaired or calibrated unit is shipped back to the customer, as it is at this time that the work is completed.

Other

The majority of the Company’s revenues are from contracts with the U.S. government, airlines, aircraft manufacturers, such as Boeing and Lockheed Martin, domestic distributors, international distributors for sales to military and commercial customers, and other commercial customers. The contracts with the U.S. government typically are subject to the Federal Acquisition Regulation (“FAR”) which provides guidance on the types of costs that are allowable in establishing prices for goods and services provided under U.S. government contracts.

Payment terms and conditions vary by contract, although terms include a requirement of payment within a range from 30 to 60 days, or in certain cases, up-front deposits. In circumstances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined that the Company's contracts do not include a significant financing component. Payments received prior to the delivery of units or services performed are recorded as deferred revenues. Taxes collected from customers, which are subsequently remitted to governmental authorities, are excluded from sales. The Company applied the practical expedient to account for shipping and handling activities as fulfillment cost rather than as a separate performance obligation. Shipping and handling costs charged to customers are classified as sales, and the shipping and handling costs incurred are included in cost of sales. All sales are denominated in U.S. dollars.

The Company chose to apply the available practical expedient as commission eligible sales orders are fulfilled within less than one year and commissions are generally paid by the Company within 30 days of the related sales order fulfillment. Accordingly, management has determined that no change in accounting for costs to obtain a contract will be required for the Company to conform to ASC 606.

Disaggregation of revenue

In the following tables, revenue is disaggregated by revenue category.

	For the Three Months Ended June 30, 2022
	Commercial		Government
Sales Distribution
Test Units	$	107,950	$	1,604,150
	$	107,950	$	1,604,150

The remainder of our revenues for the three months ended June 30, 2022, are derived from repairs and calibration of $475,034,

replacement parts of $28,327, extended warranties of $23,541 and other revenues of $14,755. We do not disaggregate these revenue streams as they are not deemed an important element related to how management operates the business between segments.

	For the Three Months Ended June 30, 2021
	Commercial		Government
Sales Distribution
Test Units	$	42,465	$	3,569,603
	$	42,465	$	3,569,603

10

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 2 – Summary of Significant Accounting Policies (continued)

The remainder of our revenues for the three months ended June 30, 2021, are derived from repairs and calibration of $445,030 replacement parts of $56,460, extended warranties of $15,915 and other revenues of $2,920. We do not disaggregate these revenue streams as they are not deemed an important element related to how management operates the business between segments.

In the following table, revenue is disaggregated by geography.

	For the Three Months Ended June 30, 2022		For the Three Months Ended June 30, 2021
Geography
United States	$	1,900,929	$	2,449,414
International		352,828		1,682,979
Total	$	2,253,757	$	4,132,393

For the three months ended June 30, 2022, three customers accounted for sales of $566,154, $459,351 and $294,398 or 25%, 20% and 13% respectively.

For the three months ended June 30, 2021, four customers accounted for sales of $1,071,934, $878,334, $741,812 and $423,284 or 26%, 21%, 18%, and 10% respectively.

The Company, in addition to inside sales efforts, utilizes independent sales agents to sell its products to customers. A related party independent sales agent earned $11,160 and $33,390 in commissions for the three months ended June 30, 2022 and June 30, 2021, respectively. The sales agent earned $9,000 for sales and marketing assistance for the three months ended June 30, 2022 and June 30, 2021, respectively.

New Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13 Financial Instruments -Credit Losses (Topic 326), Measurement of Credit Losses on Financial Statements. The amendment in this update replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses on instruments within its scope, including trade receivables. This update is intended to provide financial statement users with more decision-useful information about the expected credit losses. The effective date of the new standard has been deferred to April 1, 2023. We do not expect the adoption of this standard to have a significant impact on our financial position and results of operations.

No other recently issued accounting pronouncements had or are expected to have a material impact on the Company’s unaudited condensed consolidated financial statements.

Note 3 – Accounts Receivable, net

The following table sets forth the components of accounts receivable:

	June 30, 2022			March 31, 2022
Government	$	1,005,132		$	697,731
Commercial		374,620			358,734
Less: Allowance for doubtful accounts		(7,425	)		(7,425	)
	$	1,372,327		$	1,049,040

Note 4 – Restricted Cash to Support Appeal Bond

In January 2018, the Company transferred $2,000,000 to a restricted cash account to secure a letter of credit which was used for collateral for the appeal bond (See Note 11).

11

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 5 – Inventories, net

Inventories consist of:

	June 30, 2022			March 31, 2022
Purchased parts	$	2,450,523		$	2,371,105
Work-in-process		733,425			962,460
Less: Inventory reserve		(488,020	)		(513,068	)
	$	2,695,928		$	2,820,497

Note 6 – Net (Loss) Income per Share

Net income (loss) per share has been computed according to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC 260”), “Earnings per Share,” which requires a dual presentation of basic and diluted income per share (“EPS”). Basic EPS represents net income (loss) divided by the weighted average number of common shares outstanding during a reporting period. Diluted EPS reflects the potential dilution that could occur if securities, including preferred stock, warrants and options, were converted into common stock. The dilutive effect of outstanding warrants and options is reflected in earnings per share by use of the treasury stock method. The dilutive effect of preferred stock is reflected in earnings per share by use of the if-converted method. In applying the treasury stock method for stock-based compensation arrangements, the assumed proceeds are computed as the sum of the amount the employee must pay upon exercise and the amounts of average unrecognized compensation.  For the three months ended June 30, 2022, since the Company has a net loss, the effect of common stock equivalents is anti-dilutive, and as such, common stock equivalents have been excluded from this calculation.

	Three Months Ended			Three Months Ended
	June 30, 2022			June 30, 2021
Basic net income (loss) per share computation:
Net(loss) income	$	(232,869	)	$	575,501
Less: Preferred dividends		(80,000	)		(80,000	)
Net income attributable to common shareholders		(312,869	)		495,501
Weighted-average common shares outstanding		3,255,887			3,255,887
Basic net (loss) income per share	$	(0.10	)	$	0.15
Diluted net income per share computation
Net (loss) income attributable to common shareholders	$	(312,869	)	$	495,501
Add: Preferred dividends		-			80,000
Diluted income attributable to common shareholders	$	(312,869	)	$	575,501
Weighted-average common shares outstanding		3,255,887			3,255,887
Incremental shares attributable to the assumed conversion of preferred stock		-			1,839,778
Total adjusted weighted-average shares		3,255,887			5,095,665
Diluted net income per share	$	(0.10	)	$	0.11

The following table summarizes securities that, if exercised, would have an anti-dilutive effect on earnings per share for the three months ended:

	June 30, 2022		June 30, 2021
Convertible preferred stock		1,839,778		-
Stock options		111,500		98,500
		1,951,278		98,500

12

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 7 – Line of Credit

The Company has a line of credit with Bank of America with open availability up to $690,000. The borrowing base calculation is tied to accounts receivable and is collateralized by substantially all of the assets of the Company. Interest on any outstanding balance is payable monthly at an annual interest rate equal to the LIBOR (London Interbank Offered Rates) daily float plus 3.75 percentage points. On July 29, 2022, Bank of America extended the maturity date of the line of credit from July 30, 2022 to July 30, 2023.

As of June 30, 2022 and March 31, 2022 the line of credit draw remained at zero balance.

Note 8 – Segment Information

In accordance with FASB ASC 280, “Disclosures about Segments of an Enterprise and related information”, the Company determined it has two reportable segments - avionics government and avionics commercial. There are no inter-segment revenues.

The Company is organized primarily on the basis of its avionics products. The avionics government segment consists primarily of the design, manufacture, and sale of test equipment to the U.S. and foreign governments and militaries either directly or through distributors. The avionics commercial segment consists of design, manufacture, and sale of test equipment to domestic and foreign airlines, directly or through commercial distributors, and to general aviation repair and maintenance shops. The Company develops and designs test equipment for the avionics industry and as such, the Company’s products and designs cross segments.

Management evaluates the performance of its segments and allocates resources to them based on gross margin. The Company’s general and administrative costs and sales and marketing expenses, and engineering costs are not segment specific. As a result, all operating expenses are not managed on a segment basis. Net interest includes expenses on debt and income earned on cash balances, both maintained at the corporate level.

The tables below present information about reportable segments within the avionics business for the three months ending June 30, 2022, and 2021:

Three Months Ended June 30, 2022	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	1,604,150	$	649,607	$	2,253,757	$	-		$	2,253,757
Cost of sales		962,236		456,336		1,418,572		-			1,418,572
Gross margin		641,914		193,271		835,185		-			835,185
Engineering, research, and development						522,103		-			522,103
Selling, general and administrative						172,851		383,358			556,209
Litigation costs						-		724			724
Interest income						-		(986	)		(986	)
Interest expense – judgment						-		51,920			51,920
Total expenses						694,954		435,016			1,129,970
Income (loss) before income taxes					$	140,231	$	(435,016	)	$	(294,785	)

Three Months Ended June 30, 2021	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	3,569,603	$	562,790	$	4,132,393	$	-		$	4,132,393
Cost of sales		1,762,900		354,746		2,117,646		-			2,117,646
Gross margin		1,806,703		208,044		2,014,747		-			2,014,747
Engineering, research, and development						693,575		-			693,575
Selling, general and administrative						177,792		376,239			554,031
Litigation costs						-		1,181			1,181
Interest income						-		(984	)		(984	)
Other income						-		(13,593	)		(13,593	)
Interest expense - judgment						-		51,920			51,920
Total expenses (income)						871,367		414,763			1,286,130
Income (loss) before income taxes					$	1,143,380	$	(414,763	)	$	728,617

13

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 9 – Income Taxes

FASB ASC 740-10, “Accounting for Uncertainty in Income Taxes” (“ASC 740-10”) prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The Company has analyzed filing positions in all of the federal and state jurisdictions where it is required to file income tax returns, as well as all open tax years in these jurisdictions. The Company does not have any unrecognized tax benefits.

The tax effect of temporary differences, primarily net operating loss carryforwards, asset reserves and accrued liabilities, gave rise to the Company’s deferred tax asset. Deferred income taxes are recognized for the tax consequence of such temporary differences at the enacted tax rate expected to be in effect when the differences reverse. The Company had approximately $2.6 million in deferred tax assets at June 30, 2022 and approximately $2.5 million in deferred tax assets at March 31, 2022. The Company recognizes the impact of an uncertain income tax position taken on its income tax return at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority.

The net loss was $232,869 for the three months ended June 30, 2022, resulting in income tax benefit of $61,916 and increase in NOL for the three months ended June 30, 2022.

Note 10– Operating Lease Liability

The Company leases its facility in East Rutherford, NJ with monthly payments of $21,237 until August 2025. Thereafter, monthly payments are $23,083 for the balance of the 8 year lease agreement expiring August 2029.

The Company's leases generally do not provide an implicit rate, and therefore the Company uses its incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease. The Company estimated its incremental borrowing rate based on its credit quality, line of credit agreement and by comparing interest rates available in the market for similar borrowings. The Company used a discount rate of 3.90% for both June 30, 2022 and March 31, 2022, respectively.

The following table reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancelable operating leases with terms of more than one year to the total lease liabilities recognized on the unaudited condensed consolidated balance sheet as of June 30, 2022:

Remaining payments 2023	$	191,130
2024		254,840
2025		254,840
2026		267,767
2027		277,000
Thereafter		669,416
Total undiscounted future minimum lease payments		1,914,993
Less: Difference between undiscounted lease payments and discounted lease liabilities		(241,957	)
Present value of net minimum lease payments		1,673,036
Less current portion		(196,271	)
Operating lease liabilities – long-term	$	1,476,765

Total rent expense for the three months ended June 30, 2022, was $103,908, as compared to $92,134 for the three months ended June 30, 2021.

14

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 11 – Litigation

Contingencies are recorded in the consolidated financial statements when it is probable that a liability will be incurred and the amount of the loss is reasonably estimable, or otherwise disclosed, in accordance with Accounting Standards Codification 450, Contingencies (ASC 450). Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. In the event the Company determines that a loss is not probable, but is reasonably possible, and it becomes possible to develop what the Company believes to be a reasonable range of possible loss, then the Company will include disclosures related to such matter as appropriate and in compliance with ASC 450. To the extent there is a reasonable possibility that the losses could exceed the amounts already accrued, the Company will, when applicable, adjust the accrual in the period the determination is made, disclose an estimate of the additional loss or range of loss or if the amount of such adjustment cannot be reasonably estimated, disclose that an estimate cannot be made. On March 24, 2009, Aeroflex Wichita, Inc. (“Aeroflex”) filed a petition against the Company and two of its employees in the District Court located in Sedgwick County, Kansas, Case No. 09 CV 1141 (the “Aeroflex Action”), alleging that the Company and its two employees misappropriated Aeroflex’s proprietary technology in connection with the Company winning a substantial contract from the U.S. Army, to develop new Mode-5 radar test sets and kits to upgrade the existing TS-4530 radar test sets to Mode 5 (the “Award”). Aeroflex’s petition, seeking injunctive relief and damages, alleges that in connection with the Award, the Company and its named employees misappropriated Aeroflex’s trade secrets; tortiously interfered with Aeroflex’s business relationship; conspired to harm Aeroflex and tortiously interfered with Aeroflex’s contract. The central basis of all the claims in the Aeroflex Action is that the Company misappropriated and used Aeroflex proprietary technology and confidential information in winning the Award. In February 2009, subsequent to the Company winning the Award, Aeroflex filed a protest of the Award with the Government Accounting Office (“GAO”). In its protest, Aeroflex alleged, inter alia, that the Company used Aeroflex’s proprietary technology in order to win the Award, the same material allegations as were later alleged in the Aeroflex Action. On or about March 17, 2009, the U.S. Army Contracts Attorney, and the U.S. Army Contracting Officer each filed a statement with the GAO, expressly rejecting Aeroflex’s allegations that the Company used or infringed on Aeroflex’s proprietary technology in winning the Award and concluding that the Company had used only its own proprietary technology. On April 6, 2009, Aeroflex withdrew its protest.

In December 2009, the Kansas District Court dismissed the Aeroflex Action on jurisdiction grounds. Aeroflex appealed this decision. In May 2012, the Kansas Supreme Court reversed the decision and remanded the Aeroflex Action to the Kansas District Court for further proceedings. The case then entered an extended discovery period in the District Court.

On May 23, 2016, the Company filed a motion for summary judgment based on Aeroflex’s lack of jurisdictional standing to bring the case. The motion asserts that Aeroflex does not own the intellectual property at issue since it is a bare licensee of Northrop Grumman. Northrop Grumman has declined to join this suit as plaintiff. The motion asserted Aeroflex lacks standing to sue alone. Also, the motion raises the fact that Aeroflex allowed the license to expire, Aeroflex’s claims are either moot or Aeroflex lacks standing to sue for damages alleged to have accrued after the license ended in 2011. The motion for summary judgment was denied.

The Aeroflex trial on remand in the Kansas District Court began in March 2017. After a nine-week trial, the jury rendered its verdict. The jury found no misappropriation of Aeroflex trade secrets, but it did rule that the Company tortiously interfered with a prospective business opportunity and awarded damages of $1.3 million for lost profits. The jury also ruled that Tel tortiously interfered with Aeroflex’s non-disclosure agreements with two former Aeroflex employees and awarded damages of $1.5 million for lost profits, resulting in total damages against the Company of $2.8 million. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex and awarded damages against these two individuals totaling $525,000. The jury also decided that punitive damages should be allowed against the Company.

Following the verdict, the Company filed a motion for judgment as a matter of law. In the motion, the Company renewed its motion for judgment on Aeroflex’s tortious interference with prospective business opportunity claim arguing that such claim is barred by the statute of limitations. Alternatively, the motion asserts there is insufficient evidence supporting the lost profit award on that claim. Additionally, the motion for judgment addresses inconsistency between the awards against the former Aeroflex employees for breach of the non-disclosure agreements and the award against the Company for interfering with those agreements. Alternatively, the motion asserts there is insufficient evidence supporting the lost profit award on that claim.

During July 2017, the Court heard the Company’s motion for judgment as well as conducting a hearing as to the amount of a punitive damages award. Kansas statutes limit punitive damages to a maximum of $5 million.

15

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 11 – Litigation (continued)

Aeroflex submitted a motion to the Court requesting that the judge award punitive damages at the maximum $5 million amount. In October 2017, the Court denied the Company’s motions and awarded Aeroflex an additional $2.1 million of punitive damages, which brings the total Tel damages awarded in this case to approximately $4.9 million.

The journal entry of judgment including judgment against the Company in the amount of $1.3 million for tortious interference with prospective business advantage, of $1.5 million for tortious interference with existing contracts, and $2.1 million in punitive damages was entered on November 22, 2017. Pursuant to K.S.A. 16-204(d) “any judgment rendered by a court of this state on or after July 1, 1986, shall bear interest on and after the day on which judgment is rendered at the rate provided by subsection (e). The Kansas Secretary of State publishes the rate amount. The amount published for July 1, 2017, through June 30, 2018, was 5.75%, 6.5% July 1, 2018, through June 30, 2019, 7.0% July 1, 2019, through June 30, 2020, and 4.25% July 1, 2020 through June 30, 2021. The interest rate through June 30, 2022 was 4.25%. Interest on the $4,900,000 judgment started to accrue on November 22, 2017, the date the judgment was entered. As of June 30, 2022, the outstanding amount of the judgement and accrued interest is $6,149,193.

The Company filed post-trial motions to avoid damage duplication and inconsistency, and to secure judgment as a matter of law or a new trial. The trial court denied those motions. The Company appealed the verdict and the post-trial rulings to the Court of Appeals of the State of Kansas, Case No. 18-119,563. The Company posted a $2 million supersedeas bond. The Plaintiff filed a cross-appeal. The appeal and cross-appeal are fully briefed. The appellate court has not set a date to hear the appeal.

The Company is very optimistic about the prospects of its appeal for a judgment as a matter of law. The Company was hoping for a decision from the court this calendar year, but this timing will likely be delayed due to the three month COVID-19 related shutdown of the Kansas court system. The appeal decision has been delayed due to the COVID-19 related shutdown of the Kansas court system and the inability of court staff to work remotely on confidentiality issues. During August 2021, in an effort to move the appeal forward, all parties agreed to supply the appeal information to the court on a dedicated and secured laptop that would be used by the research attorney remotely. The Company has the ability to settle this case at its sole discretion by withdrawing the appeal and paying the judgment plus interest amount. The Company currently has sufficient cash on hand to pay off this liability if the appeal is lost.

On January 28, 2022, Aeroflex filed a Motion to Require Supplemental Appeal Bond with the Court of Appeals of the State of Kansas, seeking a bond from the Company in the amount of $6 million to supplement the existing bond of $2 million. The Company has filed a response and we are confident that this motion will be denied.

Other than the matters outlined above, we are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of executive officers of our Company, threatened against or affecting our Company, or our common stock in which an adverse decision could have a material effect.

Note 12 – Stock Options

The Board of Directors (the “Board”) adopted on January 18, 2017, and ratified by the shareholders at the Annual Meeting on January 18, 2017, the Company’s 2016 Stock Option Plan (the “Plan”). The Plan provides for the granting of incentive stock options, by a committee to be appointed by the Board (both the Board and the Committee are referred to herein as the “Committee”) to directors, officers, and employees (excluding directors and officers who are not employees) to purchase shares of the Common Stock of the Company, par value $0.10 per share (the “Stock”), in accordance with the terms and provisions. The 2016 Plan reserves for issuance, options to purchase up to 250,000 shares of its common stock. Options granted under the plan are exercisable up to a period of five years from the date of grant at an exercise price which is not less than the fair market value of the common stock at the date of grant, except to a shareholder owning 10% or more of the outstanding common stock of the Company, as to which the exercise price must be not less than 110% of the fair market value of the common stock at the date of grant. Options are exercisable on a cumulative basis, 20% at or after each of the first, second, and third anniversary of the grant and 40% after the fourth year anniversary.

16

TEL-INSTRUMENT ELECTRONICS CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 12 – Stock Options (continued)

A summary of the status of the Company’s stock option plans for the fiscal year ended March 31, 2022, and year to date June 30, 2022, and changes during the year are presented below (in number of options):

	Number of Options		Average Exercise Price		Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding options at April 1, 2022		111,500	$	3.14	2.72 years	$	3,680
Options granted		-	$	-
Options exercised		-	$	-
Options canceled/forfeited		-	$	-
Outstanding options at June 30, 2022		111,500	$	3.14	2.47 years	$	-
Vested Options:
June 30, 2022:		50,100	$	3.20	1.8 years	$	-

Remaining options available for grant were 138,500 as of June 30, 2022.

At June 2022, the unamortized compensation expense for stock options was $39,690. Unamortized compensation expense is expected to be recognized over a weighted-average period of approximately 2.5 years.

For the three months ended June 30, 2022, the Company recorded stock compensation costs of $6,235, as compared to $6,168 for the three months ended June 30, 2021.

17

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward Looking Statements

This Quarterly Report on Form 10-Q and other reports filed by the Company from time to time with the SEC (collectively the “Filings”) contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company’s management as well as estimates and assumptions made by Company’s management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used in the Filings, the words “may,” “will,” “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” or the negative of these terms and similar expressions as they relate to the Company or the Company’s management are intended to identify forward-looking statements. Such statements reflect the current view of the Company with respect to future events and we caution you that these statements are not guarantees of future performance or events and are subject to risks, assumptions, and other factors. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

Our unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us to make certain estimates, judgments, and assumptions. We believe that the estimates, judgments, and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments, and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our unaudited condensed consolidated financial statements would be affected to the extent there are material differences between these estimates and actual results. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application. There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result. The following discussion should be read in conjunction with our financial statements and notes thereto appearing elsewhere in this report.

Overview

The Company reported net loss of $232,869 and net sales of $2,253,757 for the three months ended June 30, 2022. This compared to net income of $575,501 and net sales of $4,132,393 for the same three period in the prior fiscal year.

The net loss for the three months ended June 30, 2022 was primarily caused by supply chain procurement issues. Sales declined approximately $1.9 million and gross margin percentage decreased 12% for the current versus prior three month period in the prior fiscal year or 37% versus 49%, respectively. Long supplier lead lines have been unprecedented, preventing the timely production of finished units being shipped to customers. Additionally, inflationary prices have resulted in costs in many cases increasing up to 34% for the same components purchased the same time in the prior year.

Backlog orders on June 30, 2022, were $2.7 million versus $6.1 million on June 30, 2021. The Company’s backlog on March 31, 2022, was $3.5 million. The decline is due to substantially reduced international bookings compared to the last several years. It is expected that a contract with the U.S. Navy to upgrade the CRAFT test set will be issued in August which will increase the back-log by $2.8 million.

The Company continues to pursue opportunities in the domestic and international market for our Mode 5 test sets with good results. We continue to receive volume orders from South Korea, Australia, Canada, the U.K., and Germany for our Mode 5 test sets. We also expect a large follow-on order from the German government this year. We continue to receive orders from the U.S. Government and Lockheed Martin for our AN/USM-708 and 719 (“CRAFT”) Mode 5 test sets. Our expectation is that orders and back-log will improve this fiscal year as several large production and engineering development contracts are expected. The mid-life update of our CRAFT product line will entail $2.8 million of funded engineering starting this fiscal year. This should also generate significant production revenues over the next three to seven years as key PCB’s are upgraded to remove obsolescence. We are also in preliminary negotiations with the U.S. Army on a funded software upgrade to the TS-4530A product.

18

Overview (continued)

TIC is also exploring new avenues to broaden its product portfolio including designing a high frequency test set for the Lockheed Martin F-35 program. This contract takes advantage of our expertise in RF technology. This is a completely new market for TIC as it involves high frequency communication signals. This contract includes non-recurring engineering funding and expected annual production revenues in the $600,000 range. TIC has completed the test readiness review (“TRR”) and is almost done with the required environmental testing. The development contract should be completed in the current fiscal quarter TIC will continue to explore funded engineering programs of this nature as this is high margin business that helps diversify and expand our product portfolio.

The main focus area for the Company is moving into the secure communications testing. The key for long-term sustained growth will be to supplement our strong position in military Mode 5 transponder testing with dominant product offerings in the much larger commercial and military communications and navigation test set market. TIC has spent several years and millions of dollars in developing our ground-breaking SDR/OMNI product which is meant to address both the commercial market for transponder and navigation test sets as well as competing in the military secure comm test set market. The SDR/OMNI supports a wide frequency range to accommodate new commercial and military waveforms in an industry leading 4-pound package. This is approximately half the weight of competitive test sets. It is also the only new multi-purpose test set which meets the Class 1 military environmental specifications. It utilizes the latest touch screen technology and has the capability to replace all TIC commercial test sets and military flight-line test sets with one handheld product. The engineering design on this test set has been completed and we are currently in the process of demonstrating this product to customers and performing product verification. The Company has begun taking customer orders with production deliveries expected to commence in the September/October timeframe. There are several companies competing in this market space, but we believe that our SDR/OMNI design will be extremely competitive, particularly for military applications.

The Aeroflex litigation did not result in a favorable outcome for the Company, despite our belief that we committed no wrongdoing. The jury found no misappropriation of Aeroflex trade secrets, but it did rule that the Company tortiously interfered with a prospective business opportunity and awarded damages. The jury also ruled that Tel tortiously interfered with Aeroflex’s non-disclosure agreements with two former Aeroflex employees. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex. The Court conducted further hearings on the Company’s post-trial motions which sought to reduce the damages award of $2.8 million, as well as the punitive damages claim. The Court denied the Company’s motions and awarded Aeroflex an additional $2.1 million of punitive damages. The Company has filed motions in January 2018 for the Court to reconsider the number of damages on the grounds that they are duplicative and not legally supportable. The Court heard these motions, and such motions were denied. The Company filed for an appeal during 2019. The Company has posted a $2 million bond for the appeal. This $2 million bond amount will remain in place during the appeal process. The appeal process has effectively been in limbo for several years due to the Kansas Supreme Court moving to remote work. The case documents are sealed, and the court has not responded to our repeated scheduling update requests. We believe we have strong appeal grounds, and the plan is to wait for the eventual decision despite the negative impact of the interest accruals on our financial results. The best case scenario is that the award is vacated while the worst-case scenario would be a dismissal which would require TIC to pay the judgement amount plus accrued interest.

Results of Operations

Sales

Net sales were $2,253,757 for the three months ended June 30, 2022, as compared to $4,132,393 for the same three month period in the prior fiscal year. The decrease in sales of $1,878,636 (45%) was due primarily to supply chain issues, where supplier lead times have increased from several months to over six months in some cases. In particular, chip components have been especially difficult to receive on a timely basis by our PCB vendors.

Gross Margin

For the three months ended June 30, 2022, total gross margin decreased $1,179,562 (12%) to $835,185 as compared to $2,014,747 for the three months ended June 30, 2021. The gross margin percentage for the three months ended June 30, 2022, was 37% as compared to 49% for the three months ended June 30, 2021. The decrease in gross margin percentage was primarily volume related with the fixed production costs spread over a lower revenue base, and parts component costs for hard to find obsolete parts rising sharply over the last 12 months had  a significant impact on the Company’s gross margins.

19

Operating Expenses

Selling, general and administrative expenses increased $2,178 for the three months ended June 30, 2022 to $556,209, as compared to $554,031 for the three months ended June 30, 2021. The nominal net increase is a result of lower sales commissions, consultant fees, and profit sharing accruals, offset by the resuming of travel and trade show participation.

Aeroflex litigation costs were nominal at $724 for the three months ended June 30,2022 as compared to $1,181 for the same period in the previous year. With respect to the Aeroflex litigation, the Company has appealed the $4.9 million judgement and has set aside $2 million in cash to support an appeal bond. The Company is optimistic about the prospects of its appeal for a judgment as a matter of law. The appeal decision has been delayed due to the COVID-19 related shutdown of the Kansas court system and the inability of court staff to work remotely on confidentiality issues. During August 2021, in an effort to move the appeal forward, all parties agreed to supply the appeal information to the court on a dedicated and secured laptop that would be used by the research attorney remotely. The Company has the ability to settle this case at its sole discretion by withdrawing the appeal and paying the judgment plus interest amount. The Company currently has sufficient cash on hand to pay off this liability if the appeal is lost. On January 28, 2022, Aeroflex filed a Motion to Require Supplemental Appeal Bond with the Court of Appeals of the State of Kansas, seeking a bond from the Company in the amount of $6 million to supplement the existing bond of $2 million. The Company has filed a response and we are confident that this motion will be denied.

Engineering, research, and development expenses decreased $171,472 (25%) to $522,103 for the three months ended June 30, 2022, as compared to $693,575 for the three months ended June 30, 2021. Total engineering expense decreased primarily as a result of the restart of the Lockheed Martin MADL program which reduced engineering costs in the current quarter by $110,514, with the balance of the decrease a result of cost efficiencies.

Income (Loss) from Operations

As a result of the above, the Company recorded a loss from operations of $243,851 for the three months ended June 30, 2022, as compared to income from operations of $765,960 for the three months ended June 30, 2021.

Other Expenses, Net

For the three ended June 30, 2022, total other expenses, net was ($50,934) as compared to $(37,343) for the three months ended June 30, 2021.The $13,591(36%) increase in expense is primarily a result of non-repeat federal COVID payroll tax credits totaling $9,999 and $4,500 of other income during the three months ended June 30, 2021.

Income before Income Taxes

The Company recorded a net loss before taxes of $294,785 for the three months ended June 30, 2022, as compared to income before taxes of $728,617 for the three months ended June 30, 2021.

Income Tax (Benefit) Expense

For the three months ended June 30, 2022, the Company recorded an income tax benefit of $61,916 and related increase in its deferred tax asset, as a result of the Company’s net loss for the respective quarter, as compared to $153,116 tax expense for the three months ended June 30, 2021.

Net Income (Loss)

The Company recorded a net loss of $232,869 for the three months ended June 30, 2022, as compared to net income of $575,501 for the three months ended June 30, 2021.

Liquidity and Capital Resources

At June 30, 2022, the Company had net working capital of $3,274,114 including accrued legal damages related to the Aeroflex litigation of $6,149,193, as compared to working capital of $3,671,667 at March 31, 2022. This change is due primarily to the decline in sales revenue and profitability.

20

During the three months ended June 30, 2022, the Company’s cash balance (including the $2 million in restricted cash for the appeal) decreased by $699,896 to $6,260,844. The Company’s principal sources, and uses of funds were as follows:

Cash (used in) provide by operating activities. For the three months ended June 30, 2022, $608,163 in cash from operations was used, as compared to the three months ended June 30, 2021, the Company provided $1,353,544. This decrease in cash provided for operations is mostly attributed to the net loss for the quarter, an increase in accounts receivable, and a decrease in accounts payable.

Cash used in investing activities. For the three months ended June 30, 2022, the Company used $11,733 in equipment asset activities as compared to zero for the three months ended June 30, 2021.

Cash used in financing activities. For the three months ended June 30, 2022, the Company used $80,000 in cash from financing activities as compared to the same amount of $80,000 for the three months ended June 30,2021. The funds were used to pay dividends in both the current and prior comparative periods.

The Bank of America line of credit was renewed and will mature July 30, 2023. As of June 30, 2022, the line of credit draw remained at zero.

On June 30, 2022, the Company had $6.3 million of cash on hand which included $2 million of restricted cash supporting the appeal bond.

As of June 30, 2022, the Company had recorded total damages of $6,149,193 including accrued interest, as a result of the jury verdict associated with the Aeroflex litigation as well as the Court’s decision on punitive damages. The Company has recorded accrued interest of $1,249,193 as of June 30, 2022.

The Company is very optimistic about the prospects of its appeal for a judgment as a matter of law. Due to the three-month COVID-19 related shutdown of the Kansas court system and subsequent partial reopening of the court system, a major backlog has resulted. As such, the appeal process is expected to take at least another year to complete unless a settlement can be reached. The Company has the ability to settle this case at its sole discretion by withdrawing the appeal and paying the judgment plus interest amount. The Company currently has sufficient cash on hand to pay off this liability if we lose the appeal.

Moving forward, we believe that our expected cash flows from operations and current cash balances, which amounted to approximately $6.3 million, including the approximately $2 million in restricted cash will be sufficient to operate in the normal course of business for next 12 months from the issuance date of these unaudited condensed financial statements, including any payments for settlement of the litigation.

Currently, the Company has no material future capital expenditure requirements.

These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on For 10-K for the fiscal year ended March 31, 2022, filed with the SEC on June 17, 2022 (the “Annual Report”).

Off-Balance Sheet Arrangements

As of June 30, 2022, the Company had no off-balance sheet arrangements.

Critical Accounting Policies

Our critical accounting policies are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report. There have been no changes in our critical accounting policies. Our significant accounting policies are described in our notes to the 2022 consolidated financial statements included in our Annual Report.

21

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

We do not hold any derivative instruments and do not engage in any hedging activities.

Item 4. Controls and Procedures.

(a) Evaluation of Disclosure Controls and Procedures

The Company, including its principal executive officer and principal financial officer, conducted an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”) as of the end of the period covered by this report (the “Evaluation Date”). Based upon the evaluation, our principal executive officer and principal financial officer concluded as of the Evaluation Date that our disclosure controls and procedures were effective. Disclosure controls are controls and procedures designed to reasonably ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this report, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls include controls and procedures designed to reasonably ensure that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

(b) Changes in Internal Control over Financial Reporting

The Company, including its chief executive officer and chief financial officer, reviewed the Company’s internal control over financial reporting, pursuant to Rule 13(a)-15(e) under the Exchange Act and concluded that there was no change in the Company’s internal control over financial reporting during the Company’s most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

22

PART II – OTHER INFORMATION

Item 1. Legal Proceedings.

The Aeroflex litigation (see Note 11) to the Unaudited Condensed Consolidated Financial Statements) did not result in a favorable outcome for the Company, despite our belief that we committed no wrong-doing.

The jury found no misappropriation of Aeroflex trade secrets but found that the Company tortiously interfered with a prospective business opportunity and awarded damages. The jury also ruled that Tel tortiously interfered with Aeroflex’s non-disclosure agreements with two former Aeroflex employees. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex. The Court conducted further hearings on the Company’s post-trial motions which sought to reduce the damages award of $2.8 million, as well as the punitive damages claim. The Court denied the Company’s motions and awarded Aeroflex an additional $2.1 million of punitive damages. The Company has filed motions in January 2018 for the Court to reconsider the amount of damages on the grounds that they are duplicative and not legally supportable. The Court heard these motions, and such motions were denied. In 2019 the Company filed for an appeal. The Company has posted a $2 million bond for the appeal. This $2 million bond amount will remain in place during the appeal process (See Note 4).

As reflected in the accompanying unaudited condensed consolidated balance sheet as of June 30, 2022, the Company has recorded estimated damages to date of approximately $6.1 million, including interest, as a result of a jury verdict associated with the Aeroflex litigation. The Company has filed for an appeal (see Notes 4 and 11). As of June 30, 2022, the Company has cash balances of $6.3 million, including $2 million of restricted cash as well as $1.4 million in accounts receivable. We expect to continue to have sufficient cash to fully cover the Aeroflex damages amount.

The appeal decision has been delayed due to the COVID-19 related shutdown of the Kansas court system and the inability of court staff to work remotely on confidentiality issues. During August 2021, in an effort to move the appeal forward, all parties agreed to supply the appeal information to the court on a dedicated and secured laptop that would be used by the research attorney remotely. The Company has the ability to settle this case at its sole discretion by withdrawing the appeal and paying the judgment plus interest amount. The Company currently has sufficient cash on hand to pay off this liability if the appeal is lost.

On January 28, 2022, Aeroflex filed a Motion to Require Supplemental Appeal Bond with the Court of Appeals of the State of Kansas, seeking a bond from the Company in the amount of $6 million to supplement the existing bond of $2 million. The Company has filed a response and we are confident that this motion will be denied. The Company continue to wait for the Kansas court system to communicate any updates.

Other than the matters outlined above, we are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of executive officers of our Company, threatened against or affecting our Company, or our common stock in which an adverse decision could have a material effect.

Item 1A. Risk Factors.

We believe there are no changes that constitute material changes from the risk factors previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, filed with the SEC on June 17, 2022.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

There were no unregistered sales of the Company’s equity securities during the quarter ended June 30, 2022.

Item 3. Defaults upon Senior Securities.

There has been no default in the payment of principal, interest, sinking or purchase fund installment, or any other material default, with respect to any indebtedness of the Company.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

There is no other information required to be disclosed under this item which was not previously disclosed.

23

Item 6. Exhibits.

Exhibit No.	Description
31.1	Certification of Principal Executive Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 302 of 2002*
31.2	Certification of Principal Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 302 of 2002*
32.1	Certification of Principal Executive Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
32.2	Certification of Principal Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
101.INS	Inline XBRL Instance Document*
101.SCH	Inline XBRL Taxonomy Extension Schema Document*
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document*
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document*
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*

* Filed herewith

24

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	TEL-INSTRUMENT ELECTRONICS CORP.
Date: August 15, 2022	By:	/s/ Jeffrey C. O’Hara
		Name: Jeffrey C. O’Hara
		Title: Chief Executive Officer (Principal Executive Officer)

25

EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Jeffrey C. O’Hara, certify that:

1. I have reviewed this Form 10-Q of Tel-Instrument Electronics Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;

4. Along with the Principal Financial Officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 15, 2022	By:	/s/ Jeffrey C. O’Hara
		Jeffrey C. O’Hara
		Chief Executive Officer (Principal Executive Officer)

EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

I, Pauline X. Romeo, certify that:

1. I have reviewed this Form 10-Q of Tel-Instrument Electronics Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods present in this report;

4. Along with the Principal Executive Officer, I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13-a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involved management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 15, 2022	By:	/s/ Pauline X. Romeo
		Pauline X. Romeo
		Chief Accounting Officer (Principal Financial and Accounting Officer)

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report of Tel-Instrument Electronics Corp. (the “Company”), on Form 10-Q for the quarter ended June 30, 2022, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Jeffrey C. O’Hara, Principal Executive Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) Such Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in such Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 15, 2022	By:	/s/ Jeffrey C. O’Hara
		Jeffrey C. O’Hara
		Chief Executive Officer (Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF

THE SARBANES-OXLEY ACT OF 2002

In connection with this Quarterly Report of Tel-Instrument Electronics Corp. (the “Company”), on Form 10-Q for the quarter ended June 30, 2022, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Pauline X. Romeo, Chief Accounting Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) Such Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in such Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 15, 2022	By:	/s/ Pauline X. Romeo
		Pauline X. Romeo
		Chief Accounting Officer (Principal Financial and Accounting Officer)

XML

Document And Entity Information - shares	3 Months Ended
	Jun. 30, 2022	Aug. 11, 2022
Document Information Line Items
Entity Registrant Name	TEL-INSTRUMENT ELECTRONICS CORP.
Trading Symbol	N/A
Document Type	10-Q
Current Fiscal Year End Date	--03-31
Entity Common Stock, Shares Outstanding		3,255,887
Amendment Flag	false
Entity Central Index Key	0000096885
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Jun. 30, 2022
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-31990
Entity Incorporation, State or Country Code	NJ
Entity Tax Identification Number	22-1441806
Entity Address, Address Line One	One Branca Road
Entity Address, City or Town	East Rutherford
Entity Address, State or Province	NJ
Entity Address, Postal Zip Code	07073
City Area Code	201
Local Phone Number	933-1600
Title of 12(b) Security	N/A
Security Exchange Name	NONE
Entity Interactive Data Current	Yes

XML

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2022	Mar. 31, 2022
Current assets:
Cash	$ 4,249,794	$ 4,949,690
Accounts receivable, net of allowance for doubtful accounts of $7,425, respectively	1,372,327	1,049,040
Inventories, net	2,695,928	2,820,497
Restricted cash to support appeal bond	2,011,050	2,011,050
Prepaid expenses and other current assets	399,118	244,040
Total current assets	10,728,217	11,074,317
Equipment and leasehold improvements, net	111,127	115,338
Operating lease right-of-use assets	1,673,036	1,720,921
Deferred tax asset, net	2,561,504	2,499,587
Other long-term assets	35,109	35,109
Total assets	15,108,993	15,445,272
Current liabilities:
Operating lease liabilities – current portion	196,271	194,370
Accounts payable	167,426	406,489
Deferred revenues - current portion	170,575	119,835
Accrued expenses ‐vacation pay, payroll and payroll withholdings	424,781	410,538
Accrued legal damages	6,149,193	6,097,273
Accrued expenses - other	345,857	174,145
Total current liabilities	7,454,103	7,402,650
Operating lease liabilities – long-term	1,476,765	1,526,551
Deferred revenues – long-term	257,759	289,071
Total liabilities	9,188,627	9,218,272
Commitments and contingencies
Stockholders’ equity:
Preferred stock
Common stock, 7,000,000 shares authorized, par value $0.10 per share, 3,255,887 and 3,255,887 shares issued and outstanding, respectively	325,586	325,586
Additional paid-in capital	6,944,588	7,018,353
Accumulated deficit	(6,193,173)	(5,960,304)
Total stockholders’ equity	5,920,366	6,227,000
Total liabilities and stockholders’ equity	15,108,993	15,445,272
Series A Preferred Stock [Member]
Stockholders’ equity:
Preferred stock	3,695,998	3,695,998
Series B Preferred Stock [Member]
Stockholders’ equity:
Preferred stock	$ 1,147,367	$ 1,147,367

XML

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)	3 Months Ended	12 Months Ended
	Jun. 30, 2022	Mar. 31, 2022
Accounts receivable, allowance for doubtful accounts (in Dollars)	$ 7,425	$ 7,425
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, par value (in Dollars per share)	$ 0.1	$ 0.1
Common stock, par value (in Dollars per share)	$ 0.1	$ 0.1
Common stock, shares issued	3,255,887	3,255,887
Common stock, shares outstanding	3,255,887	3,255,887
Common stock, shares authorized	7,000,000	7,000,000
Series A Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.1	$ 0.1
Preferred stock, shares issued	500,000	500,000
Preferred stock, shares outstanding	500,000	500,000
Preferred stock, Cumulative Series Convertible Preferred	8.00%	8.00%
Series B Preferred Stock [Member]
Preferred stock, par value (in Dollars per share)	$ 0.1	$ 0.1
Preferred stock, shares issued	166,667	166,667
Preferred stock, shares outstanding	166,667	166,667
Preferred stock, Cumulative Series Convertible Preferred	8.00%	8.00%

XML

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Net sales	$ 2,253,757	$ 4,132,393
Cost of sales	1,418,572	2,117,646
Gross margin	835,185	2,014,747
Operating expenses:
Selling, general and administrative	556,209	554,031
Litigation expenses	724	1,181
Engineering, research, and development	522,103	693,575
Total operating expenses	1,079,036	1,248,787
(Loss) income from operations	(243,851)	765,960
Other (expense) income:
Interest income	986	984
Other income	0	13,593
Interest expense – judgement	(51,920)	(51,920)
Total other expense, net	(50,934)	(37,343)
(Loss) income before income taxes	(294,785)	728,617
Income tax (benefit) expense	(61,916)	153,116
Net (loss) income	(232,869)	575,501
Preferred dividends	(80,000)	(80,000)
Net (loss) income attributable to common shareholders	$ (312,869)	$ 495,501
Basic net (loss) income per common share (in Dollars per share)	$ (0.1)	$ 0.15
Diluted net (loss) income per common share (in Dollars per share)	$ (0.1)	$ 0.11
Weighted average shares outstanding:
Basic (in Shares)	3,255,887	3,255,887
Diluted (in Shares)	3,255,887	5,095,665

XML

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)	Series A Preferred Stock [Member] Preferred Stock [Member]	Series B Preferred Stock [Member] Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balances at Mar. 31, 2021	$ 3,695,998	$ 1,147,367	$ 325,586	$ 7,318,620	$ (7,270,042)	$ 5,217,529
Balances (in Shares) at Mar. 31, 2021	500,000	166,667	3,255,887
8% Dividends on Preferred Stock	$ 60,000	$ 20,000		(80,000)		80,000
Dividend Payments	(60,000)	(20,000)				(80,000)
Stock-based compensation				6,168		6,168
Net income					575,501	575,501
Balances at Jun. 30, 2021	$ 3,695,998	$ 1,147,367	$ 325,586	7,244,788	(6,694,541)	5,719,198
Balances (in Shares) at Jun. 30, 2021	500,000	166,667	3,255,887
Balances at Mar. 31, 2022	$ 3,695,998	$ 1,147,367	$ 325,586	7,018,353	(5,960,304)	$ 6,227,000
Balances (in Shares) at Mar. 31, 2022	500,000	166,667	3,255,887			3,255,887
8% Dividends on Preferred Stock	$ 60,000	$ 20,000		(80,000)		$ 80,000
Dividend Payments	(60,000)	(20,000)				(80,000)
Stock-based compensation				6,235		6,235
Net income					(232,869)	(232,869)
Balances at Jun. 30, 2022	$ 3,695,998	$ 1,147,367	$ 325,586	$ 6,944,588	$ (6,193,173)	$ 5,920,366
Balances (in Shares) at Jun. 30, 2022	500,000	166,667	3,255,887			3,255,887

XML

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Parentheticals)	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Additional Paid-in Capital [Member]
Dividends on Preferred Stock	8.00%	8.00%

XML

Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Statement of Cash Flows [Abstract]
Net (loss) income	$ (232,869)	$ 575,501
Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities
Deferred income taxes	(61,917)	153,114
Depreciation and amortization	15,944	31,381
Non-cash lease expense	47,885	55,300
(Recovery of) provision for inventory obsolescence	(25,048)	0
Non-cash stock-based compensation	6,235	6,168
(Increase) decrease in accounts receivable	(323,287)	615,045
Decrease in inventories	149,617	386,646
(Increase) decrease in prepaid expenses & other assets	(155,078)	3,514
(Decrease) in accounts payable and other accrued liabilities	(67,351)	(555,716)
Increase in accrued payroll, vacation pay and payroll taxes	14,243	84,842
Increase in deferred revenues	19,428	1,129
(Decrease) in operating lease liabilities	(47,885)	(55,300)
Increase in accrued legal damages	51,920	51,920
Net cash (used in) provided by operating activities	(608,163)	1,353,544
Cash flows from investing activities:
Purchases of equipment	(11,733)	0
Net cash used in investing activities	(11,733)	0
Payment of dividends	(80,000)	(80,000)
Net cash used in financing activities	(80,000)	(80,000)
Net (decrease) increase in cash and restricted cash	(699,896)	1,273,544
	6,960,740	5,496,325
Supplemental cash flow information:
Taxes paid	0	0
Interest paid	0	0
	6,260,844	6,769,869
Beginning of period
Cash	4,949,690	3,485,275
Restricted cash	2,011,050	2,011,050
End of period
Cash	4,249,794	4,758,819
Restricted cash	$ 2,011,050	$ 2,011,050

XML

Supplemental disclosure of non-cash financing activities:

3 Months Ended

Jun. 30, 2022

Supplemental Cash Flow Elements [Abstract]

Cash Flow, Supplemental Disclosures [Text Block]

Supplemental disclosure of non-cash financing activities:

XML

Business, Organization, and Liquidity

3 Months Ended

Jun. 30, 2022

Accounting Policies [Abstract]

Basis of Accounting [Text Block]

Note 1 – Business, Organization and Liquidity

Business and Organization

Tel-Instrument Electronics Corp. (“Tel,” “TIC” or the “Company”) has been in business since 1947. The Company is a leading designer and manufacturer of avionics test and measurement instruments for the global, commercial air transport, general aviation, and government/military defense markets. Tel provides instruments to test, measure, calibrate, and repair a wide range of airborne navigation and communication equipment. The Company sells its equipment in both domestic and international markets. Tel continues to develop new products in anticipation of customers’ needs and to maintain its strong market position. Its development of multi-function testers has made it easier for customers to perform ramp tests with less operator training, fewer test sets, and lower product support costs. The Company has become a major manufacturer and supplier of Identification Friend or Foe (“IFF”) flight line test equipment over the last two decades.

The Company is publicly traded and was quoted on the Over-the-Counter Market Place (“OTCQB”) under the symbol “TIKK.”

Liquidity

On June 30, 2022, the Company had positive working capital of $3,274,114, as compared to working capital of $3,671,667 on March 31, 2022. This included $6.3 million of cash including the $2 million supersedes appeal bond. The Company also has current borrowing capacity of $690,000 under the Company’s line of credit agreement. The Company has recorded total damages of $6,149,193, including accrued interest, as a result of the jury verdict associated with the Aeroflex litigation as well as the Court’s decision on punitive damages.

There was a $2.7 million sales order backlog on June 30, 2022.

Bank of America has renewed our line of credit with a maturity date of July 30, 2023. As of June 30, 2022, the line of credit draw remains at zero, with $690,000 available.

Moving forward, we believe that our expected cash flows from operations and current cash balances, which amounted to approximately $6.3 million, including the approximately $2 million in restricted cash will be sufficient to operate in the normal course of business for next 12 months from the issuance date of these unaudited condensed consolidated financial statements, including any payments for settlement of the litigation. We are currently seeing supply chain lead times improving enough to allow fulfillment of our back log orders for the balance of the fiscal year.

Currently, the Company has no material future capital expenditure requirements.

In December 2019, a novel strain of coronavirus, which causes the disease known as COVID-19, was reported to have surfaced in Wuhan, China. Since then, COVID-19 coronavirus has spread globally. In March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic and the U.S. government imposed travel restrictions on travel between the United States, Europe, and certain other countries. The impact of this pandemic has been, and will likely continue to be, extensive in many aspects of society, which has resulted, and will likely continue to result, in significant disruptions to the global economy as well as businesses and capital markets around the world.

Impact of the COVID-19 Coronavirus

On September 9, 2021, President Biden announced Executive Order 14042 (“Executive Order”) and related initiatives designed to lead the country out of the COVID-19 pandemic. The Executive Order includes policies that will require employees of contractors that do business with the federal government to be vaccinated. On September 24, 2021, The Safer Federal Workforce Task Force released COVID-19 vaccine guidance for Federal contractors and subcontractors. According to this guidance, covered employees must be fully vaccinated by December 8, 2021, or at the latest, by the first day of performance on a covered contract, absent the need for a disability or religious accommodation. In addition, covered contractors must follow the CDC’s mask and physical distance requirements for covered contractor employees and visitors. The Executive Order and the guidance apply to any prime contractor or subcontractor that is a party to a “contract or contract-like instrument” that includes a clause incorporating the requirements of the Executive Order. The new clause was applied on October 15, 2021, to only new federal contracts, solicitations, contract extensions and renewals.

On December 7, 2021, the federal court in Georgia issued a preliminary injunction temporarily halting the enforcement of EO 14042 (Ensuring Adequate COVID Safety Protocols for Federal Contractors) for all covered contracts nation-wide. New guidance from OMB also followed suit giving federal agencies input on how to go about non-enforcement provisions until legal challenges have been resolved. The updated guidance will remain applicable despite any change to new or existing court decisions. The new guidance does not impact the Safer Federal Workforce Taskforce Guidance. The Government will take no action to enforce the clause implementing requirements of Executive Order 14042, absent further written notice from the agency, where the place of performance identified in the contract is in a U.S. state or outlying area subject to a court order prohibiting the application of requirements pursuant to the Executive Order (hereinafter, “Excluded State or Outlying Area”). In all other circumstances, the Government will enforce the clause, except for contractor employees who perform substantial work on or in connection with a covered contract in an Excluded State or Outlying Area, or in a covered contractor workplace located in an Excluded State or Outlying Area.

XML

Summary of Significant Accounting Policies

3 Months Ended

Jun. 30, 2022

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Tel-Instrument Electronics Corp. as of June 30, 2022, the results of operations, change in stockholders’ equity for the three months ended June 30, 2022 and June 30, 2021, and statements of cash flow for the three months ended June 30, 2022 and June 30, 2021. These results are not necessarily indicative of the results to be expected for the full year. The unaudited condensed consolidated financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include disclosures normally made in an Annual Report on Form 10-K. The March 31, 2022, balance sheet included herein was derived from the audited financial statements included in the Company’s Annual Report on Form 10-K as of that date. Accordingly, the unaudited condensed consolidated financial statements included herein should be reviewed in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, as filed with the United States Securities and Exchange Commission (the “SEC”) on June 17, 2022 (the “Annual Report”).

Revenue Recognition

Under Financial Accounting Standards Board (“FASB”) Topic 606, Revenue from Contacts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods or services, in an amount that reflects the consideration which is expected to be received in exchange for those goods or services. The Company recognizes revenue following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods and services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.

The Company accounts for revenue recognition in accordance with ASC 606.The core principle of Topic 606 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The ASC 606 defines a five-step process to achieve the core principle and, in doing so, it is possible more judgement and estimates may be required within the revenue recognition process than are currently in use.

The Company generates revenue from designing, manufacturing, and selling avionic tests and measurement solutions for the global commercial air transport, general aviation, and government/military aerospace and defense markets. The Company also offers calibration and repair services for a wide range of airborne navigation and communication equipment.

Nature of goods and services

The following is a description of the products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each.

Test Units/Sets

The Company develops and manufactures unit sets to test navigation and communication equipment, such as ramp testers and bench testers for equipment installed in aircraft and ground radios. The Company recognizes revenue when the customer obtains control of the Company’s product based on the contractual shipping terms of the contract, which is usually at the time of shipment. Revenue on products is presented gross because the Company is primarily responsible for fulfilling the promise to provide the product, is responsible to ensure that the product is produced in accordance with the related supply agreement and bears the risk of loss while the inventory is in-transit. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products to the customer.

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines stand-alone selling prices based on the price at which the performance obligation is sold separately. If the stand-alone selling price is not observable through past transactions, the Company estimates the standalone selling price considering available information such as market conditions and internally approved pricing guidelines related to the performance obligations.

When determining the transaction price of a contract, an adjustment is made if payment from the customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying the practical expedient in paragraph 606-10-32-18, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less. None of the Company’s contracts contained a significant financing component as of June 30, 2022.

Replacement Parts

The Company offers replacement parts for test equipment, ramp testers, and bench testers. Similar to the sale of test sets, the control of the product transfers at a point of time and therefore, revenue is recognized at the point in time when the obligation to the customer has been fulfilled.

Extended Warranties

The extended warranties sold by the Company provide a level of assurance beyond the coverage for defects that existed at the time of a sale or against certain types of covered damage with coverage terms ranging from 3 to 7 years. Amounts received for warranties are recorded as deferred revenue and recognized as revenue ratably over the respective term of the agreements. As of June 30, 2022, $366,966 is expected to be recognized from remaining obligations for extended warranties as compared to $386,907 at March 31, 2022. For the three months ended June 30, 2022, the Company recognized revenue of $23,541 from amounts that were included in Deferred Revenue as compared to $15,915 from amounts that were included in Deferred Revenue for the three months ended June 30, 2021.

The following table provides a summary of the changes in deferred revenues for the three months ended June 30, 2022:

Deferred revenues at April 1, 2022	$	386,907
Additional extended warranties		3,600
Revenue recognized for the three months ended June 30, 2022		(23,541	)
Deferred revenues at June 30, 2022	$	366,966

Other Deferred Revenues

The Company sometimes receives payments in advance of shipment. These amounts are classified as other deferred revenues. For the periods ended June 30, 2022, and March 31, 2022, the Company had other deferred revenues of $61,368 and $21,999, respectively.

Repair and Calibration Services

The Company offers repair and calibration services for units that are returned for annual calibrations and/or for repairs after the warranty period has expired. The Company repairs and calibrates a wide range of airborne navigation and communication equipment. Revenue is recognized at the time the repaired or calibrated unit is shipped back to the customer, as it is at this time that the work is completed.

Other

The majority of the Company’s revenues are from contracts with the U.S. government, airlines, aircraft manufacturers, such as Boeing and Lockheed Martin, domestic distributors, international distributors for sales to military and commercial customers, and other commercial customers. The contracts with the U.S. government typically are subject to the Federal Acquisition Regulation (“FAR”) which provides guidance on the types of costs that are allowable in establishing prices for goods and services provided under U.S. government contracts.

Payment terms and conditions vary by contract, although terms include a requirement of payment within a range from 30 to 60 days, or in certain cases, up-front deposits. In circumstances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined that the Company's contracts do not include a significant financing component. Payments received prior to the delivery of units or services performed are recorded as deferred revenues. Taxes collected from customers, which are subsequently remitted to governmental authorities, are excluded from sales. The Company applied the practical expedient to account for shipping and handling activities as fulfillment cost rather than as a separate performance obligation. Shipping and handling costs charged to customers are classified as sales, and the shipping and handling costs incurred are included in cost of sales. All sales are denominated in U.S. dollars.

The Company chose to apply the available practical expedient as commission eligible sales orders are fulfilled within less than one year and commissions are generally paid by the Company within 30 days of the related sales order fulfillment. Accordingly, management has determined that no change in accounting for costs to obtain a contract will be required for the Company to conform to ASC 606.

Disaggregation of revenue

In the following tables, revenue is disaggregated by revenue category.

	For the Three Months Ended June 30, 2022
	Commercial		Government
Sales Distribution
Test Units	$	107,950	$	1,604,150
	$	107,950	$	1,604,150

The remainder of our revenues for the three months ended June 30, 2022, are derived from repairs and calibration of $475,034,

replacement parts of $28,327, extended warranties of $23,541 and other revenues of $14,755. We do not disaggregate these revenue streams as they are not deemed an important element related to how management operates the business between segments.

	For the Three Months Ended June 30, 2021
	Commercial		Government
Sales Distribution
Test Units	$	42,465	$	3,569,603
	$	42,465	$	3,569,603

The remainder of our revenues for the three months ended June 30, 2021, are derived from repairs and calibration of $445,030 replacement parts of $56,460, extended warranties of $15,915 and other revenues of $2,920. We do not disaggregate these revenue streams as they are not deemed an important element related to how management operates the business between segments.

In the following table, revenue is disaggregated by geography.

	For the Three Months Ended June 30, 2022		For the Three Months Ended June 30, 2021
Geography
United States	$	1,900,929	$	2,449,414
International		352,828		1,682,979
Total	$	2,253,757	$	4,132,393

For the three months ended June 30, 2022, three customers accounted for sales of $566,154, $459,351 and $294,398 or 25%, 20% and 13% respectively.

For the three months ended June 30, 2021, four customers accounted for sales of $1,071,934, $878,334, $741,812 and $423,284 or 26%, 21%, 18%, and 10% respectively.

The Company, in addition to inside sales efforts, utilizes independent sales agents to sell its products to customers. A related party independent sales agent earned $11,160 and $33,390 in commissions for the three months ended June 30, 2022 and June 30, 2021, respectively. The sales agent earned $9,000 for sales and marketing assistance for the three months ended June 30, 2022 and June 30, 2021, respectively.

New Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13 Financial Instruments -Credit Losses (Topic 326), Measurement of Credit Losses on Financial Statements. The amendment in this update replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses on instruments within its scope, including trade receivables. This update is intended to provide financial statement users with more decision-useful information about the expected credit losses. The effective date of the new standard has been deferred to April 1, 2023. We do not expect the adoption of this standard to have a significant impact on our financial position and results of operations.

No other recently issued accounting pronouncements had or are expected to have a material impact on the Company’s unaudited condensed consolidated financial statements.

XML

Accounts Receivable, net

3 Months Ended

Jun. 30, 2022

Receivables [Abstract]

Loans, Notes, Trade and Other Receivables Disclosure [Text Block]

Note 3 – Accounts Receivable, net

The following table sets forth the components of accounts receivable:

	June 30, 2022			March 31, 2022
Government	$	1,005,132		$	697,731
Commercial		374,620			358,734
Less: Allowance for doubtful accounts		(7,425	)		(7,425	)
	$	1,372,327		$	1,049,040

XML

Restricted Cash to Support Appeal Bond

3 Months Ended

Jun. 30, 2022

Cash and Cash Equivalents [Abstract]

Cash and Cash Equivalents Disclosure [Text Block]

Note 4 – Restricted Cash to Support Appeal Bond

In January 2018, the Company transferred $2,000,000 to a restricted cash account to secure a letter of credit which was used for collateral for the appeal bond (See Note 11).

XML

Inventories, net

3 Months Ended

Jun. 30, 2022

Inventory Disclosure [Abstract]

Inventory Disclosure [Text Block]

Note 5 – Inventories, net

Inventories consist of:

	June 30, 2022			March 31, 2022
Purchased parts	$	2,450,523		$	2,371,105
Work-in-process		733,425			962,460
Less: Inventory reserve		(488,020	)		(513,068	)
	$	2,695,928		$	2,820,497

XML

Net (Loss) Income per Share

3 Months Ended

Jun. 30, 2022

Earnings Per Share [Abstract]

Earnings Per Share [Text Block]

Note 6 – Net (Loss) Income per Share

Net income (loss) per share has been computed according to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC 260”), “Earnings per Share,” which requires a dual presentation of basic and diluted income per share (“EPS”). Basic EPS represents net income (loss) divided by the weighted average number of common shares outstanding during a reporting period. Diluted EPS reflects the potential dilution that could occur if securities, including preferred stock, warrants and options, were converted into common stock. The dilutive effect of outstanding warrants and options is reflected in earnings per share by use of the treasury stock method. The dilutive effect of preferred stock is reflected in earnings per share by use of the if-converted method. In applying the treasury stock method for stock-based compensation arrangements, the assumed proceeds are computed as the sum of the amount the employee must pay upon exercise and the amounts of average unrecognized compensation.  For the three months ended June 30, 2022, since the Company has a net loss, the effect of common stock equivalents is anti-dilutive, and as such, common stock equivalents have been excluded from this calculation.

	Three Months Ended			Three Months Ended
	June 30, 2022			June 30, 2021
Basic net income (loss) per share computation:
Net(loss) income	$	(232,869	)	$	575,501
Less: Preferred dividends		(80,000	)		(80,000	)
Net income attributable to common shareholders		(312,869	)		495,501
Weighted-average common shares outstanding		3,255,887			3,255,887
Basic net (loss) income per share	$	(0.10	)	$	0.15
Diluted net income per share computation
Net (loss) income attributable to common shareholders	$	(312,869	)	$	495,501
Add: Preferred dividends		-			80,000
Diluted income attributable to common shareholders	$	(312,869	)	$	575,501
Weighted-average common shares outstanding		3,255,887			3,255,887
Incremental shares attributable to the assumed conversion of preferred stock		-			1,839,778
Total adjusted weighted-average shares		3,255,887			5,095,665
Diluted net income per share	$	(0.10	)	$	0.11

The following table summarizes securities that, if exercised, would have an anti-dilutive effect on earnings per share for the three months ended:

	June 30, 2022		June 30, 2021
Convertible preferred stock		1,839,778		-
Stock options		111,500		98,500
		1,951,278		98,500

XML

Line of Credit

3 Months Ended

Jun. 30, 2022

Debt Disclosure [Abstract]

Debt Disclosure [Text Block]

Note 7 – Line of Credit

The Company has a line of credit with Bank of America with open availability up to $690,000. The borrowing base calculation is tied to accounts receivable and is collateralized by substantially all of the assets of the Company. Interest on any outstanding balance is payable monthly at an annual interest rate equal to the LIBOR (London Interbank Offered Rates) daily float plus 3.75 percentage points. On July 29, 2022, Bank of America extended the maturity date of the line of credit from July 30, 2022 to July 30, 2023.

As of June 30, 2022 and March 31, 2022 the line of credit draw remained at zero balance.

XML

Segment Information

3 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Note 8 – Segment Information

In accordance with FASB ASC 280, “Disclosures about Segments of an Enterprise and related information”, the Company determined it has two reportable segments - avionics government and avionics commercial. There are no inter-segment revenues.

The Company is organized primarily on the basis of its avionics products. The avionics government segment consists primarily of the design, manufacture, and sale of test equipment to the U.S. and foreign governments and militaries either directly or through distributors. The avionics commercial segment consists of design, manufacture, and sale of test equipment to domestic and foreign airlines, directly or through commercial distributors, and to general aviation repair and maintenance shops. The Company develops and designs test equipment for the avionics industry and as such, the Company’s products and designs cross segments.

Management evaluates the performance of its segments and allocates resources to them based on gross margin. The Company’s general and administrative costs and sales and marketing expenses, and engineering costs are not segment specific. As a result, all operating expenses are not managed on a segment basis. Net interest includes expenses on debt and income earned on cash balances, both maintained at the corporate level.

The tables below present information about reportable segments within the avionics business for the three months ending June 30, 2022, and 2021:

Three Months Ended June 30, 2022	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	1,604,150	$	649,607	$	2,253,757	$	-		$	2,253,757
Cost of sales		962,236		456,336		1,418,572		-			1,418,572
Gross margin		641,914		193,271		835,185		-			835,185
Engineering, research, and development						522,103		-			522,103
Selling, general and administrative						172,851		383,358			556,209
Litigation costs						-		724			724
Interest income						-		(986	)		(986	)
Interest expense – judgment						-		51,920			51,920
Total expenses						694,954		435,016			1,129,970
Income (loss) before income taxes					$	140,231	$	(435,016	)	$	(294,785	)

Three Months Ended June 30, 2021	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	3,569,603	$	562,790	$	4,132,393	$	-		$	4,132,393
Cost of sales		1,762,900		354,746		2,117,646		-			2,117,646
Gross margin		1,806,703		208,044		2,014,747		-			2,014,747
Engineering, research, and development						693,575		-			693,575
Selling, general and administrative						177,792		376,239			554,031
Litigation costs						-		1,181			1,181
Interest income						-		(984	)		(984	)
Other income						-		(13,593	)		(13,593	)
Interest expense - judgment						-		51,920			51,920
Total expenses (income)						871,367		414,763			1,286,130
Income (loss) before income taxes					$	1,143,380	$	(414,763	)	$	728,617

XML

Income Taxes

3 Months Ended

Jun. 30, 2022

Income Tax Disclosure [Abstract]

Income Tax Disclosure [Text Block]

Note 9 – Income Taxes

FASB ASC 740-10, “Accounting for Uncertainty in Income Taxes” (“ASC 740-10”) prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The Company has analyzed filing positions in all of the federal and state jurisdictions where it is required to file income tax returns, as well as all open tax years in these jurisdictions. The Company does not have any unrecognized tax benefits.

The tax effect of temporary differences, primarily net operating loss carryforwards, asset reserves and accrued liabilities, gave rise to the Company’s deferred tax asset. Deferred income taxes are recognized for the tax consequence of such temporary differences at the enacted tax rate expected to be in effect when the differences reverse. The Company had approximately $2.6 million in deferred tax assets at June 30, 2022 and approximately $2.5 million in deferred tax assets at March 31, 2022. The Company recognizes the impact of an uncertain income tax position taken on its income tax return at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority.

The net loss was $232,869 for the three months ended June 30, 2022, resulting in income tax benefit of $61,916 and increase in NOL for the three months ended June 30, 2022.

XML

Operating Lease Liability

3 Months Ended

Jun. 30, 2022

Disclosure Text Block [Abstract]

Lessee, Operating Leases [Text Block]

Note 10– Operating Lease Liability

The Company leases its facility in East Rutherford, NJ with monthly payments of $21,237 until August 2025. Thereafter, monthly payments are $23,083 for the balance of the 8 year lease agreement expiring August 2029.

The Company's leases generally do not provide an implicit rate, and therefore the Company uses its incremental borrowing rate as the discount rate when measuring operating lease liabilities. The incremental borrowing rate represents an estimate of the interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease. The Company estimated its incremental borrowing rate based on its credit quality, line of credit agreement and by comparing interest rates available in the market for similar borrowings. The Company used a discount rate of 3.90% for both June 30, 2022 and March 31, 2022, respectively.

The following table reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancelable operating leases with terms of more than one year to the total lease liabilities recognized on the unaudited condensed consolidated balance sheet as of June 30, 2022:

Remaining payments 2023	$	191,130
2024		254,840
2025		254,840
2026		267,767
2027		277,000
Thereafter		669,416
Total undiscounted future minimum lease payments		1,914,993
Less: Difference between undiscounted lease payments and discounted lease liabilities		(241,957	)
Present value of net minimum lease payments		1,673,036
Less current portion		(196,271	)
Operating lease liabilities – long-term	$	1,476,765

Total rent expense for the three months ended June 30, 2022, was $103,908, as compared to $92,134 for the three months ended June 30, 2021.

XML

Litigation

3 Months Ended

Jun. 30, 2022

Disclosure Text Block Supplement [Abstract]

Legal Matters and Contingencies [Text Block]

Note 11 – Litigation

Contingencies are recorded in the consolidated financial statements when it is probable that a liability will be incurred and the amount of the loss is reasonably estimable, or otherwise disclosed, in accordance with Accounting Standards Codification 450, Contingencies (ASC 450). Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. In the event the Company determines that a loss is not probable, but is reasonably possible, and it becomes possible to develop what the Company believes to be a reasonable range of possible loss, then the Company will include disclosures related to such matter as appropriate and in compliance with ASC 450. To the extent there is a reasonable possibility that the losses could exceed the amounts already accrued, the Company will, when applicable, adjust the accrual in the period the determination is made, disclose an estimate of the additional loss or range of loss or if the amount of such adjustment cannot be reasonably estimated, disclose that an estimate cannot be made. On March 24, 2009, Aeroflex Wichita, Inc. (“Aeroflex”) filed a petition against the Company and two of its employees in the District Court located in Sedgwick County, Kansas, Case No. 09 CV 1141 (the “Aeroflex Action”), alleging that the Company and its two employees misappropriated Aeroflex’s proprietary technology in connection with the Company winning a substantial contract from the U.S. Army, to develop new Mode-5 radar test sets and kits to upgrade the existing TS-4530 radar test sets to Mode 5 (the “Award”). Aeroflex’s petition, seeking injunctive relief and damages, alleges that in connection with the Award, the Company and its named employees misappropriated Aeroflex’s trade secrets; tortiously interfered with Aeroflex’s business relationship; conspired to harm Aeroflex and tortiously interfered with Aeroflex’s contract. The central basis of all the claims in the Aeroflex Action is that the Company misappropriated and used Aeroflex proprietary technology and confidential information in winning the Award. In February 2009, subsequent to the Company winning the Award, Aeroflex filed a protest of the Award with the Government Accounting Office (“GAO”). In its protest, Aeroflex alleged, inter alia, that the Company used Aeroflex’s proprietary technology in order to win the Award, the same material allegations as were later alleged in the Aeroflex Action. On or about March 17, 2009, the U.S. Army Contracts Attorney, and the U.S. Army Contracting Officer each filed a statement with the GAO, expressly rejecting Aeroflex’s allegations that the Company used or infringed on Aeroflex’s proprietary technology in winning the Award and concluding that the Company had used only its own proprietary technology. On April 6, 2009, Aeroflex withdrew its protest.

In December 2009, the Kansas District Court dismissed the Aeroflex Action on jurisdiction grounds. Aeroflex appealed this decision. In May 2012, the Kansas Supreme Court reversed the decision and remanded the Aeroflex Action to the Kansas District Court for further proceedings. The case then entered an extended discovery period in the District Court.

On May 23, 2016, the Company filed a motion for summary judgment based on Aeroflex’s lack of jurisdictional standing to bring the case. The motion asserts that Aeroflex does not own the intellectual property at issue since it is a bare licensee of Northrop Grumman. Northrop Grumman has declined to join this suit as plaintiff. The motion asserted Aeroflex lacks standing to sue alone. Also, the motion raises the fact that Aeroflex allowed the license to expire, Aeroflex’s claims are either moot or Aeroflex lacks standing to sue for damages alleged to have accrued after the license ended in 2011. The motion for summary judgment was denied.

The Aeroflex trial on remand in the Kansas District Court began in March 2017. After a nine-week trial, the jury rendered its verdict. The jury found no misappropriation of Aeroflex trade secrets, but it did rule that the Company tortiously interfered with a prospective business opportunity and awarded damages of $1.3 million for lost profits. The jury also ruled that Tel tortiously interfered with Aeroflex’s non-disclosure agreements with two former Aeroflex employees and awarded damages of $1.5 million for lost profits, resulting in total damages against the Company of $2.8 million. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex and awarded damages against these two individuals totaling $525,000. The jury also decided that punitive damages should be allowed against the Company.

Following the verdict, the Company filed a motion for judgment as a matter of law. In the motion, the Company renewed its motion for judgment on Aeroflex’s tortious interference with prospective business opportunity claim arguing that such claim is barred by the statute of limitations. Alternatively, the motion asserts there is insufficient evidence supporting the lost profit award on that claim. Additionally, the motion for judgment addresses inconsistency between the awards against the former Aeroflex employees for breach of the non-disclosure agreements and the award against the Company for interfering with those agreements. Alternatively, the motion asserts there is insufficient evidence supporting the lost profit award on that claim.

During July 2017, the Court heard the Company’s motion for judgment as well as conducting a hearing as to the amount of a punitive damages award. Kansas statutes limit punitive damages to a maximum of $5 million.

Aeroflex submitted a motion to the Court requesting that the judge award punitive damages at the maximum $5 million amount. In October 2017, the Court denied the Company’s motions and awarded Aeroflex an additional $2.1 million of punitive damages, which brings the total Tel damages awarded in this case to approximately $4.9 million.

The journal entry of judgment including judgment against the Company in the amount of $1.3 million for tortious interference with prospective business advantage, of $1.5 million for tortious interference with existing contracts, and $2.1 million in punitive damages was entered on November 22, 2017. Pursuant to K.S.A. 16-204(d) “any judgment rendered by a court of this state on or after July 1, 1986, shall bear interest on and after the day on which judgment is rendered at the rate provided by subsection (e). The Kansas Secretary of State publishes the rate amount. The amount published for July 1, 2017, through June 30, 2018, was 5.75%, 6.5% July 1, 2018, through June 30, 2019, 7.0% July 1, 2019, through June 30, 2020, and 4.25% July 1, 2020 through June 30, 2021. The interest rate through June 30, 2022 was 4.25%. Interest on the $4,900,000 judgment started to accrue on November 22, 2017, the date the judgment was entered. As of June 30, 2022, the outstanding amount of the judgement and accrued interest is $6,149,193.

The Company filed post-trial motions to avoid damage duplication and inconsistency, and to secure judgment as a matter of law or a new trial. The trial court denied those motions. The Company appealed the verdict and the post-trial rulings to the Court of Appeals of the State of Kansas, Case No. 18-119,563. The Company posted a $2 million supersedeas bond. The Plaintiff filed a cross-appeal. The appeal and cross-appeal are fully briefed. The appellate court has not set a date to hear the appeal.

The Company is very optimistic about the prospects of its appeal for a judgment as a matter of law. The Company was hoping for a decision from the court this calendar year, but this timing will likely be delayed due to the three month COVID-19 related shutdown of the Kansas court system. The appeal decision has been delayed due to the COVID-19 related shutdown of the Kansas court system and the inability of court staff to work remotely on confidentiality issues. During August 2021, in an effort to move the appeal forward, all parties agreed to supply the appeal information to the court on a dedicated and secured laptop that would be used by the research attorney remotely. The Company has the ability to settle this case at its sole discretion by withdrawing the appeal and paying the judgment plus interest amount. The Company currently has sufficient cash on hand to pay off this liability if the appeal is lost.

On January 28, 2022, Aeroflex filed a Motion to Require Supplemental Appeal Bond with the Court of Appeals of the State of Kansas, seeking a bond from the Company in the amount of $6 million to supplement the existing bond of $2 million. The Company has filed a response and we are confident that this motion will be denied.

Other than the matters outlined above, we are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of executive officers of our Company, threatened against or affecting our Company, or our common stock in which an adverse decision could have a material effect.

XML

Stock Options

3 Months Ended

Jun. 30, 2022

Share-Based Payment Arrangement [Abstract]

Share-Based Payment Arrangement [Text Block]

Note 12 – Stock Options

The Board of Directors (the “Board”) adopted on January 18, 2017, and ratified by the shareholders at the Annual Meeting on January 18, 2017, the Company’s 2016 Stock Option Plan (the “Plan”). The Plan provides for the granting of incentive stock options, by a committee to be appointed by the Board (both the Board and the Committee are referred to herein as the “Committee”) to directors, officers, and employees (excluding directors and officers who are not employees) to purchase shares of the Common Stock of the Company, par value $0.10 per share (the “Stock”), in accordance with the terms and provisions. The 2016 Plan reserves for issuance, options to purchase up to 250,000 shares of its common stock. Options granted under the plan are exercisable up to a period of five years from the date of grant at an exercise price which is not less than the fair market value of the common stock at the date of grant, except to a shareholder owning 10% or more of the outstanding common stock of the Company, as to which the exercise price must be not less than 110% of the fair market value of the common stock at the date of grant. Options are exercisable on a cumulative basis, 20% at or after each of the first, second, and third anniversary of the grant and 40% after the fourth year anniversary.

A summary of the status of the Company’s stock option plans for the fiscal year ended March 31, 2022, and year to date June 30, 2022, and changes during the year are presented below (in number of options):

	Number of Options		Average Exercise Price		Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding options at April 1, 2022		111,500	$	3.14	2.72 years	$	3,680
Options granted		-	$	-
Options exercised		-	$	-
Options canceled/forfeited		-	$	-
Outstanding options at June 30, 2022		111,500	$	3.14	2.47 years	$	-
Vested Options:
June 30, 2022:		50,100	$	3.20	1.8 years	$	-

Remaining options available for grant were 138,500 as of June 30, 2022.

At June 2022, the unamortized compensation expense for stock options was $39,690. Unamortized compensation expense is expected to be recognized over a weighted-average period of approximately 2.5 years.

For the three months ended June 30, 2022, the Company recorded stock compensation costs of $6,235, as compared to $6,168 for the three months ended June 30, 2021.

XML

Accounting Policies, by Policy (Policies)

3 Months Ended

Jun. 30, 2022

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Basis of Presentation

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Tel-Instrument Electronics Corp. as of June 30, 2022, the results of operations, change in stockholders’ equity for the three months ended June 30, 2022 and June 30, 2021, and statements of cash flow for the three months ended June 30, 2022 and June 30, 2021. These results are not necessarily indicative of the results to be expected for the full year. The unaudited condensed consolidated financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include disclosures normally made in an Annual Report on Form 10-K. The March 31, 2022, balance sheet included herein was derived from the audited financial statements included in the Company’s Annual Report on Form 10-K as of that date. Accordingly, the unaudited condensed consolidated financial statements included herein should be reviewed in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2022, as filed with the United States Securities and Exchange Commission (the “SEC”) on June 17, 2022 (the “Annual Report”).

Revenue [Policy Text Block]

Revenue Recognition

Under Financial Accounting Standards Board (“FASB”) Topic 606, Revenue from Contacts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods or services, in an amount that reflects the consideration which is expected to be received in exchange for those goods or services. The Company recognizes revenue following the five-step model prescribed under ASC 606: (i) identify contract(s) with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that the entity will collect the consideration it is entitled to in exchange for the goods and services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are performance obligations and assesses whether each promised good or service is distinct. The Company then recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.

The Company accounts for revenue recognition in accordance with ASC 606.The core principle of Topic 606 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The ASC 606 defines a five-step process to achieve the core principle and, in doing so, it is possible more judgement and estimates may be required within the revenue recognition process than are currently in use.

The Company generates revenue from designing, manufacturing, and selling avionic tests and measurement solutions for the global commercial air transport, general aviation, and government/military aerospace and defense markets. The Company also offers calibration and repair services for a wide range of airborne navigation and communication equipment.

Nature of goods and services

The following is a description of the products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each.

Test Units/Sets

The Company develops and manufactures unit sets to test navigation and communication equipment, such as ramp testers and bench testers for equipment installed in aircraft and ground radios. The Company recognizes revenue when the customer obtains control of the Company’s product based on the contractual shipping terms of the contract, which is usually at the time of shipment. Revenue on products is presented gross because the Company is primarily responsible for fulfilling the promise to provide the product, is responsible to ensure that the product is produced in accordance with the related supply agreement and bears the risk of loss while the inventory is in-transit. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products to the customer.

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines stand-alone selling prices based on the price at which the performance obligation is sold separately. If the stand-alone selling price is not observable through past transactions, the Company estimates the standalone selling price considering available information such as market conditions and internally approved pricing guidelines related to the performance obligations.

When determining the transaction price of a contract, an adjustment is made if payment from the customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying the practical expedient in paragraph 606-10-32-18, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less. None of the Company’s contracts contained a significant financing component as of June 30, 2022.

Replacement Parts

The Company offers replacement parts for test equipment, ramp testers, and bench testers. Similar to the sale of test sets, the control of the product transfers at a point of time and therefore, revenue is recognized at the point in time when the obligation to the customer has been fulfilled.

Extended Warranties

The extended warranties sold by the Company provide a level of assurance beyond the coverage for defects that existed at the time of a sale or against certain types of covered damage with coverage terms ranging from 3 to 7 years. Amounts received for warranties are recorded as deferred revenue and recognized as revenue ratably over the respective term of the agreements. As of June 30, 2022, $366,966 is expected to be recognized from remaining obligations for extended warranties as compared to $386,907 at March 31, 2022. For the three months ended June 30, 2022, the Company recognized revenue of $23,541 from amounts that were included in Deferred Revenue as compared to $15,915 from amounts that were included in Deferred Revenue for the three months ended June 30, 2021.

The following table provides a summary of the changes in deferred revenues for the three months ended June 30, 2022:

Deferred revenues at April 1, 2022	$	386,907
Additional extended warranties		3,600
Revenue recognized for the three months ended June 30, 2022		(23,541	)
Deferred revenues at June 30, 2022	$	366,966

Other Deferred Revenues

The Company sometimes receives payments in advance of shipment. These amounts are classified as other deferred revenues. For the periods ended June 30, 2022, and March 31, 2022, the Company had other deferred revenues of $61,368 and $21,999, respectively.

Repair and Calibration Services

The Company offers repair and calibration services for units that are returned for annual calibrations and/or for repairs after the warranty period has expired. The Company repairs and calibrates a wide range of airborne navigation and communication equipment. Revenue is recognized at the time the repaired or calibrated unit is shipped back to the customer, as it is at this time that the work is completed.

Other

The majority of the Company’s revenues are from contracts with the U.S. government, airlines, aircraft manufacturers, such as Boeing and Lockheed Martin, domestic distributors, international distributors for sales to military and commercial customers, and other commercial customers. The contracts with the U.S. government typically are subject to the Federal Acquisition Regulation (“FAR”) which provides guidance on the types of costs that are allowable in establishing prices for goods and services provided under U.S. government contracts.

Payment terms and conditions vary by contract, although terms include a requirement of payment within a range from 30 to 60 days, or in certain cases, up-front deposits. In circumstances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined that the Company's contracts do not include a significant financing component. Payments received prior to the delivery of units or services performed are recorded as deferred revenues. Taxes collected from customers, which are subsequently remitted to governmental authorities, are excluded from sales. The Company applied the practical expedient to account for shipping and handling activities as fulfillment cost rather than as a separate performance obligation. Shipping and handling costs charged to customers are classified as sales, and the shipping and handling costs incurred are included in cost of sales. All sales are denominated in U.S. dollars.

The Company chose to apply the available practical expedient as commission eligible sales orders are fulfilled within less than one year and commissions are generally paid by the Company within 30 days of the related sales order fulfillment. Accordingly, management has determined that no change in accounting for costs to obtain a contract will be required for the Company to conform to ASC 606.

Disaggregation of revenue

In the following tables, revenue is disaggregated by revenue category.

	For the Three Months Ended June 30, 2022
	Commercial		Government
Sales Distribution
Test Units	$	107,950	$	1,604,150
	$	107,950	$	1,604,150

The remainder of our revenues for the three months ended June 30, 2022, are derived from repairs and calibration of $475,034,

replacement parts of $28,327, extended warranties of $23,541 and other revenues of $14,755. We do not disaggregate these revenue streams as they are not deemed an important element related to how management operates the business between segments.

	For the Three Months Ended June 30, 2021
	Commercial		Government
Sales Distribution
Test Units	$	42,465	$	3,569,603
	$	42,465	$	3,569,603

The remainder of our revenues for the three months ended June 30, 2021, are derived from repairs and calibration of $445,030 replacement parts of $56,460, extended warranties of $15,915 and other revenues of $2,920. We do not disaggregate these revenue streams as they are not deemed an important element related to how management operates the business between segments.

In the following table, revenue is disaggregated by geography.

	For the Three Months Ended June 30, 2022		For the Three Months Ended June 30, 2021
Geography
United States	$	1,900,929	$	2,449,414
International		352,828		1,682,979
Total	$	2,253,757	$	4,132,393

For the three months ended June 30, 2022, three customers accounted for sales of $566,154, $459,351 and $294,398 or 25%, 20% and 13% respectively.

For the three months ended June 30, 2021, four customers accounted for sales of $1,071,934, $878,334, $741,812 and $423,284 or 26%, 21%, 18%, and 10% respectively.

The Company, in addition to inside sales efforts, utilizes independent sales agents to sell its products to customers. A related party independent sales agent earned $11,160 and $33,390 in commissions for the three months ended June 30, 2022 and June 30, 2021, respectively. The sales agent earned $9,000 for sales and marketing assistance for the three months ended June 30, 2022 and June 30, 2021, respectively.

New Accounting Pronouncements, Policy [Policy Text Block]

New Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13 Financial Instruments -Credit Losses (Topic 326), Measurement of Credit Losses on Financial Statements. The amendment in this update replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses on instruments within its scope, including trade receivables. This update is intended to provide financial statement users with more decision-useful information about the expected credit losses. The effective date of the new standard has been deferred to April 1, 2023. We do not expect the adoption of this standard to have a significant impact on our financial position and results of operations.

No other recently issued accounting pronouncements had or are expected to have a material impact on the Company’s unaudited condensed consolidated financial statements.

XML

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Jun. 30, 2022

Accounting Policies [Abstract]

Deferred Revenue, by Arrangement, Disclosure [Table Text Block]

The following table provides a summary of the changes in deferred revenues for the three months ended June 30, 2022:

Deferred revenues at April 1, 2022	$	386,907
Additional extended warranties		3,600
Revenue recognized for the three months ended June 30, 2022		(23,541	)
Deferred revenues at June 30, 2022	$	366,966

Disaggregation of Revenue [Table Text Block]

In the following tables, revenue is disaggregated by revenue category.

	For the Three Months Ended June 30, 2022
	Commercial		Government
Sales Distribution
Test Units	$	107,950	$	1,604,150
	$	107,950	$	1,604,150

	For the Three Months Ended June 30, 2021
	Commercial		Government
Sales Distribution
Test Units	$	42,465	$	3,569,603
	$	42,465	$	3,569,603

Revenue from External Customers by Geographic Areas [Table Text Block]

In the following table, revenue is disaggregated by geography.

	For the Three Months Ended June 30, 2022		For the Three Months Ended June 30, 2021
Geography
United States	$	1,900,929	$	2,449,414
International		352,828		1,682,979
Total	$	2,253,757	$	4,132,393

XML

Accounts Receivable, net (Tables)

3 Months Ended

Jun. 30, 2022

Receivables [Abstract]

Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]

The following table sets forth the components of accounts receivable:

	June 30, 2022			March 31, 2022
Government	$	1,005,132		$	697,731
Commercial		374,620			358,734
Less: Allowance for doubtful accounts		(7,425	)		(7,425	)
	$	1,372,327		$	1,049,040

XML

Inventories, net (Tables)

3 Months Ended

Jun. 30, 2022

Inventory Disclosure [Abstract]

Schedule of Inventory, Current [Table Text Block]

Inventories consist of:

	June 30, 2022			March 31, 2022
Purchased parts	$	2,450,523		$	2,371,105
Work-in-process		733,425			962,460
Less: Inventory reserve		(488,020	)		(513,068	)
	$	2,695,928		$	2,820,497

XML

Net (Loss) Income per Share (Tables)

3 Months Ended

Jun. 30, 2022

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

Net income (loss) per share has been computed according to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC 260”), “Earnings per Share,” which requires a dual presentation of basic and diluted income per share (“EPS”). Basic EPS represents net income (loss) divided by the weighted average number of common shares outstanding during a reporting period. Diluted EPS reflects the potential dilution that could occur if securities, including preferred stock, warrants and options, were converted into common stock. The dilutive effect of outstanding warrants and options is reflected in earnings per share by use of the treasury stock method. The dilutive effect of preferred stock is reflected in earnings per share by use of the if-converted method. In applying the treasury stock method for stock-based compensation arrangements, the assumed proceeds are computed as the sum of the amount the employee must pay upon exercise and the amounts of average unrecognized compensation.  For the three months ended June 30, 2022, since the Company has a net loss, the effect of common stock equivalents is anti-dilutive, and as such, common stock equivalents have been excluded from this calculation.

	Three Months Ended			Three Months Ended
	June 30, 2022			June 30, 2021
Basic net income (loss) per share computation:
Net(loss) income	$	(232,869	)	$	575,501
Less: Preferred dividends		(80,000	)		(80,000	)
Net income attributable to common shareholders		(312,869	)		495,501
Weighted-average common shares outstanding		3,255,887			3,255,887
Basic net (loss) income per share	$	(0.10	)	$	0.15
Diluted net income per share computation
Net (loss) income attributable to common shareholders	$	(312,869	)	$	495,501
Add: Preferred dividends		-			80,000
Diluted income attributable to common shareholders	$	(312,869	)	$	575,501
Weighted-average common shares outstanding		3,255,887			3,255,887
Incremental shares attributable to the assumed conversion of preferred stock		-			1,839,778
Total adjusted weighted-average shares		3,255,887			5,095,665
Diluted net income per share	$	(0.10	)	$	0.11

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]

	June 30, 2022		June 30, 2021
Convertible preferred stock		1,839,778		-
Stock options		111,500		98,500
		1,951,278		98,500

XML

Segment Information (Tables)

3 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The tables below present information about reportable segments within the avionics business for the three months ending June 30, 2022, and 2021:

Three Months Ended June 30, 2022	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	1,604,150	$	649,607	$	2,253,757	$	-		$	2,253,757
Cost of sales		962,236		456,336		1,418,572		-			1,418,572
Gross margin		641,914		193,271		835,185		-			835,185
Engineering, research, and development						522,103		-			522,103
Selling, general and administrative						172,851		383,358			556,209
Litigation costs						-		724			724
Interest income						-		(986	)		(986	)
Interest expense – judgment						-		51,920			51,920
Total expenses						694,954		435,016			1,129,970
Income (loss) before income taxes					$	140,231	$	(435,016	)	$	(294,785	)

Three Months Ended June 30, 2021	Avionics Government		Avionics Commercial		Avionics Total		Corporate Items			Total
Net sales	$	3,569,603	$	562,790	$	4,132,393	$	-		$	4,132,393
Cost of sales		1,762,900		354,746		2,117,646		-			2,117,646
Gross margin		1,806,703		208,044		2,014,747		-			2,014,747
Engineering, research, and development						693,575		-			693,575
Selling, general and administrative						177,792		376,239			554,031
Litigation costs						-		1,181			1,181
Interest income						-		(984	)		(984	)
Other income						-		(13,593	)		(13,593	)
Interest expense - judgment						-		51,920			51,920
Total expenses (income)						871,367		414,763			1,286,130
Income (loss) before income taxes					$	1,143,380	$	(414,763	)	$	728,617

XML

Operating Lease Liability (Tables)

3 Months Ended

Jun. 30, 2022

Disclosure Text Block [Abstract]

Lessee, Operating Lease, Liability, Maturity [Table Text Block]

The following table reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under non-cancelable operating leases with terms of more than one year to the total lease liabilities recognized on the unaudited condensed consolidated balance sheet as of June 30, 2022:

Remaining payments 2023	$	191,130
2024		254,840
2025		254,840
2026		267,767
2027		277,000
Thereafter		669,416
Total undiscounted future minimum lease payments		1,914,993
Less: Difference between undiscounted lease payments and discounted lease liabilities		(241,957	)
Present value of net minimum lease payments		1,673,036
Less current portion		(196,271	)
Operating lease liabilities – long-term	$	1,476,765

XML

Stock Options (Tables)

3 Months Ended

Jun. 30, 2022

Share-Based Payment Arrangement [Abstract]

Share-Based Payment Arrangement, Option, Activity [Table Text Block]

A summary of the status of the Company’s stock option plans for the fiscal year ended March 31, 2022, and year to date June 30, 2022, and changes during the year are presented below (in number of options):

	Number of Options		Average Exercise Price		Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding options at April 1, 2022		111,500	$	3.14	2.72 years	$	3,680
Options granted		-	$	-
Options exercised		-	$	-
Options canceled/forfeited		-	$	-
Outstanding options at June 30, 2022		111,500	$	3.14	2.47 years	$	-
Vested Options:
June 30, 2022:		50,100	$	3.20	1.8 years	$	-

XML

Business, Organization, and Liquidity (Details) - USD ($)	3 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2021	Mar. 31, 2021
Accounting Policies [Abstract]
Working Capital	$ 3,274,114	$ 3,671,667
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	6,260,844	$ 6,960,740	$ 6,769,869	$ 5,496,325
Restricted Cash, Current	2,000,000
Line of Credit Facility, Maximum Borrowing Capacity	690,000
Loss Contingency, Damages Awarded, Value	6,149,193
Backlog	2,700,000
Long-Term Line of Credit	$ 0

XML

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Mar. 31, 2022
Summary of Significant Accounting Policies (Details) [Line Items]
Extended Product Warranty Description	The extended warranties sold by the Company provide a level of assurance beyond the coverage for defects that existed at the time of a sale or against certain types of covered damage with coverage terms ranging from 3 to 7 years.
Extended Product Warranty Accrual	$ 366,966		$ 386,907
Recognition of Deferred Revenue		$ 15,915
Deferred Revenue and Credits, Current	61,368		$ 21,999
Revenues	2,253,757	4,132,393
Payments for Commissions	11,160	33,390
Repairs and Calibration [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Revenues	475,034	445,030
Replacement Parts [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Revenues	28,327	56,460
Extended Warranty [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Revenues	23,541	15,915
Other Revenue [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Revenues	14,755	2,920
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer One [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Revenues	$ 566,154	$ 1,071,934
Concentration Risk, Percentage	25.00%	26.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer Two [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Revenues	$ 459,351	$ 878,334
Concentration Risk, Percentage	20.00%	21.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer Three [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Revenues	$ 294,398	$ 741,812
Concentration Risk, Percentage	13.00%	18.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer Four [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Revenues		$ 423,284
Concentration Risk, Percentage		10.00%
Sales and Marketing Assistance [Member]
Summary of Significant Accounting Policies (Details) [Line Items]
Payments for Commissions	$ 9,000

XML

Summary of Significant Accounting Policies (Details) - Deferred Revenue, by Arrangement, Disclosure	3 Months Ended
	Jun. 30, 2022 USD ($)
Deferred Revenue, by Arrangement, Disclosure [Abstract]
Deferred revenues related to extended warranties	$ 386,907
Additional extended warranties	3,600
Revenue recognized	(23,541)
Deferred revenues related to extended warranties	$ 366,966

XML

Summary of Significant Accounting Policies (Details) - Disaggregation of Revenue - USD ($)	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Commercial Customers [Member]
Sales Distribution
Revenues	$ 107,950	$ 42,465
U.S. Government [Member]
Sales Distribution
Revenues	1,604,150	3,569,603
Test Units [Member] | Commercial Customers [Member]
Sales Distribution
Revenues	107,950	42,465
Test Units [Member] | U.S. Government [Member]
Sales Distribution
Revenues	$ 1,604,150	$ 3,569,603

XML

Summary of Significant Accounting Policies (Details) - Revenue from External Customers by Geographic Areas - USD ($)	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Geography
Revenues	$ 2,253,757	$ 4,132,393
UNITED STATES
Geography
Revenues	1,900,929	2,449,414
INTERNATIONAL
Geography
Revenues	$ 352,828	$ 1,682,979

XML

Accounts Receivable, net (Details) - Schedule of Accounts, Notes, Loans and Financing Receivable - USD ($)	Jun. 30, 2022	Mar. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Less: Allowance for doubtful accounts	$ (7,425)	$ (7,425)
Total	1,372,327	1,049,040
Government Receivables [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts Receivable	1,005,132	697,731
Commercial Receivables [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts Receivable	$ 374,620	$ 358,734

XML

Restricted Cash to Support Appeal Bond (Details) $ in Millions	Jun. 30, 2022 USD ($)
Cash and Cash Equivalents [Abstract]
Restricted Cash, Current	$ 2

XML

Inventories, net (Details) - Schedule of Inventory, Current - USD ($)	Jun. 30, 2022	Mar. 31, 2022
Schedule of Inventory, Current [Abstract]
Purchased parts	$ 2,450,523	$ 2,371,105
Work-in-process	733,425	962,460
Less: Allowance for obsolete inventory	(488,020)	(513,068)
Inventory, net	$ 2,695,928	$ 2,820,497

XML

Net (Loss) Income per Share (Details) - Schedule of Earnings Per Share, Basic and Diluted - USD ($)	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Basic net income (loss) per share computation:
Net income	$ (232,869)	$ 575,501
Less: Preferred dividends	(80,000)	(80,000)
Net income attributable to common shareholders	(312,869)	495,501
Add: Preferred dividends	0	80,000
Diluted income attributable to common shareholders	$ (312,869)	$ 575,501
Weighted-average common shares outstanding (in Shares)	3,255,887	3,255,887
Incremental shares attributable to the assumed conversion of preferred stock (in Shares)	0	1,839,778
Total adjusted weighted-average shares (in Shares)	3,255,887	5,095,665
Diluted net income per share (in Dollars per share)	$ (0.1)	$ 0.11
Basic net income per share (in Dollars per share)	$ (0.1)	$ 0.15

XML

Net (Loss) Income per Share (Details) - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share - shares	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	1,951,278	98,500
Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	1,839,778	0
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities	111,500	98,500

XML

Line of Credit (Details)	3 Months Ended
	Jun. 30, 2022 USD ($)
Line of Credit (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 690,000
Long-Term Line of Credit	$ 0
London Interbank Offered Rate (LIBOR) [Member]
Line of Credit (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate	3.75%
Line of Credit [Member]
Line of Credit (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 690,000
Line of Credit Facility, Collateral	collateralized by substantially all of the assets of the Company
Long-Term Line of Credit	$ 0

XML

Segment Information (Details)	3 Months Ended
	Jun. 30, 2022
Segment Reporting [Abstract]
Number of Reportable Segments	2

XML

Segment Information (Details) - Schedule of Segment Reporting Information, by Segment - USD ($)	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Segment Reporting Information [Line Items]
Net sales	$ 2,253,757	$ 4,132,393
Cost of Sales	1,418,572	2,117,646
Gross Margin	835,185	2,014,747
Engineering, research, and Development	522,103	693,575
Selling, general, and administrative	556,209	554,031
Litigation expenses	724	1,181
Interest income	(986)	(984)
Other income	0	(13,593)
Interest expense - judgment	51,920	51,920
Total expenses	1,129,970	1,286,130
Income (loss) before income taxes	(294,785)	728,617
Avionics Government [Member]
Segment Reporting Information [Line Items]
Net sales	1,604,150	3,569,603
Cost of Sales	962,236	1,762,900
Gross Margin	641,914	1,806,703
Avionics Commercial [Member]
Segment Reporting Information [Line Items]
Net sales	649,607	562,790
Cost of Sales	456,336	354,746
Gross Margin	193,271	208,044
Avionics Total [Member]
Segment Reporting Information [Line Items]
Net sales	2,253,757	4,132,393
Cost of Sales	1,418,572	2,117,646
Gross Margin	835,185	2,014,747
Engineering, research, and Development	522,103	693,575
Selling, general, and administrative	172,851	177,792
Litigation expenses	0	0
Interest income	0	0
Other income		0
Interest expense - judgment	0	0
Total expenses	694,954	871,367
Income (loss) before income taxes	140,231	1,143,380
Corporate Segment [Member]
Segment Reporting Information [Line Items]
Net sales	0	0
Cost of Sales	0	0
Gross Margin	0	0
Engineering, research, and Development	0	0
Selling, general, and administrative	383,358	376,239
Litigation expenses	724	1,181
Interest income	(986)	(984)
Other income		(13,593)
Interest expense - judgment	51,920	51,920
Total expenses	435,016	414,763
Income (loss) before income taxes	$ (435,016)	$ (414,763)

XML

Income Taxes (Details) - USD ($)	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Deferred Income Tax Assets, Net	$ 2,561,504		$ 2,499,587
Income (Loss) Attributable to Parent, before Tax	232,869
Income Tax Expense (Benefit)	$ (61,916)	$ 153,116

XML

Operating Lease Liability (Details) - USD ($)	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating Lease Liability (Details) [Line Items]
Operating Lease, Expense	$ 103,908	$ 92,134
Building [Member]
Operating Lease Liability (Details) [Line Items]
Operating Lease, Expense	$ 21,237
Lessee, Operating Lease, Discount Rate	3.90%
Building [Member] | Monthly Payments September 2025 [Member] | Minimum [Member]
Operating Lease Liability (Details) [Line Items]
Operating Lease, Expense	$ 23,083
Building [Member] | Monthly Payments September 2021 [Member] | Minimum [Member]
Operating Lease Liability (Details) [Line Items]
Lessee, Operating Lease, Renewal Term	8 years

XML

Operating Lease Liability (Details) - Lessee, Operating Lease, Liability, Maturity - USD ($)	Jun. 30, 2022	Mar. 31, 2022
Lessee, Operating Lease, Liability, Maturity [Abstract]
Remaining payments 2023	$ 191,130
2024	254,840
2025	254,840
2026	267,767
2027	277,000
Thereafter	669,416
Total undiscounted future minimum lease payments	1,914,993
Less: Difference between undiscounted lease payments and discounted lease liabilities	(241,957)
Present value of net minimum lease payments	1,673,036
Less current portion	(196,271)	$ (194,370)
Operating lease liabilities – long-term	$ 1,476,765	$ 1,526,551

XML

Litigation (Details) - USD ($)			3 Months Ended	12 Months Ended
	Jan. 28, 2022	Nov. 22, 2017	Jun. 30, 2022	Mar. 31, 2018
Litigation (Details) [Line Items]
Loss Contingency, Damages Awarded, Value			$ 6,149,193
Loss Contingency, Damages Sought, Value	$ 6,000,000
Loss Contingency, Accrual, Current			$ 6,149,193
Aeroflex [Member]
Litigation (Details) [Line Items]
Loss Contingency, Damages Awarded, Value				$ 4,900,000
Litigation Case, Interest Rate on Damages Awarded			4.25%
Business Opportunity [Member] | Aeroflex [Member]
Litigation (Details) [Line Items]
Loss Contingency, Damages Awarded, Value		$ 1,300,000
Non-Disclosure Agreements [Member] | Aeroflex [Member]
Litigation (Details) [Line Items]
Loss Contingency, Damages Awarded, Value		1,500,000
Total Damages Award by Court [Member] | Aeroflex [Member]
Litigation (Details) [Line Items]
Loss Contingency, Damages Awarded, Value		$ 2,800,000
Additional Punitive Damages [Member] | Aeroflex [Member]
Litigation (Details) [Line Items]
Loss Contingency, Damages Awarded, Value				2,100,000
Loss Contingency, Damages Sought, Value				$ 5,000,000

XML

Stock Options (Details) - USD ($)		3 Months Ended
	Jan. 18, 2017	Jun. 30, 2022	Jun. 30, 2021	Mar. 31, 2022
Stock Options (Details) [Line Items]
Common Stock, Par or Stated Value Per Share (in Dollars per share)	$ 0.1	$ 0.1		$ 0.1
Common Stock, Capital Shares Reserved for Future Issuance (in Shares)	250,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount		$ 39,690
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition		2 years 6 months
Share-Based Payment Arrangement, Expense		$ 6,235	$ 6,168
Share-Based Payment Arrangement, Option [Member]
Stock Options (Details) [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Terms of Award	Options granted under the plan are exercisable up to a period of five years from the date of grant at an exercise price which is not less than the fair market value of the common stock at the date of grant, except to a shareholder owning 10% or more of the outstanding common stock of the Company, as to which the exercise price must be not less than 110% of the fair market value of the common stock at the date of grant.
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period	5 years
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights	Options are exercisable on a cumulative basis, 20% at or after each of the first, second, and third anniversary of the grant and 40% after the fourth year anniversary.
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in Shares)		138,500

XML

Stock Options (Details) - Share-based Payment Arrangement, Option, Activity - USD ($)	3 Months Ended	12 Months Ended
	Jun. 30, 2022	Mar. 31, 2022
Share-based Payment Arrangement, Option, Activity [Abstract]
Outstanding, Number of Options		111,500
Outstanding, Average Exercise Price		$ 3.14
Outstanding, Average Remaining Contractual Term	2 years 5 months 19 days	2 years 8 months 19 days
Outstanding, Aggregate Intrinsic Value		$ 3,680
Balance, Average Exercise Price	50,100
Balance, Average Exercise Price	$ 3.2
Balance, Average Remaining Contractual Term	1 year 9 months 18 days
Options granted, Average Exercise Price	0
Options granted, Average Exercise Price	$ 0
Options exercised, Average Exercise Price	0
Options exercised, Average Exercise Price	$ 0
Options canceled/forfeited, Average Exercise Price	0
Options canceled/forfeited, Average Exercise Price	$ 0
Outstanding, Number of Options	111,500
Outstanding, Average Exercise Price	$ 3.14